偷窥国产在线91,亚洲无线国产观看原创,日本精品aⅴ一区二区三区,久久九九兔免费精品6

    1. 眾賞文庫
      全部分類
    2. 抗擊疫情 >
      抗擊疫情
      病毒認知 防護手冊 復工復產(chǎn) 應急預案 防控方案 英雄事跡 院務工作
    3. 成品畢設 >
      成品畢設
      外文翻譯 畢業(yè)設計 畢業(yè)論文 開題報告 文獻綜述 任務書 課程設計 相關資料 大學生活 期刊論文 實習報告
    4. 項目策劃 >
      項目策劃
      土地準備 規(guī)劃設計 開工開盤 項目綜合 竣工移交 售后移交 智慧方案 安全專項 環(huán)境影響評估報告 可行性研究報告 項目建議書 商業(yè)計劃書 危害評估防治 招投標文件
    5. 專業(yè)資料 >
      專業(yè)資料
      人文法律 環(huán)境安全 食品科學 基礎建設 能源化工 農(nóng)林牧畜 綜合待分類 教育經(jīng)驗 行政人力 企業(yè)管理 醫(yī)學衛(wèi)生 IT技術 土木建筑 考研專題 財會稅務 公路隧道 紡織服裝
    6. 共享辦公 >
      共享辦公
      總結(jié)匯報 調(diào)研報告 工作計劃 述職報告 講話發(fā)言 心得體會 思想?yún)R報 事務文書 合同協(xié)議 活動策劃 代理加盟 技術服務 求職簡歷 辦公軟件 ppt模板 表格模板 融資協(xié)議 發(fā)言演講 黨團工作 民主生活
    7. 學術文檔 >
      學術文檔
      自然科學 生物科學 天文科學 醫(yī)學衛(wèi)生 工業(yè)技術 航空、航天 環(huán)境科學、安全科學 軍事 政學 文化、科學、教育、 交通運輸 經(jīng)濟 語言、文字 文學 農(nóng)業(yè)科學 社會科學總論 藝術 歷史、地理 哲學 數(shù)理科學和化學 綜合性圖書 哲學宗教
    8. 經(jīng)營營銷 >
      經(jīng)營營銷
      綜合文檔 經(jīng)濟財稅 人力資源 運營管理 企業(yè)管理 內(nèi)控風控 地產(chǎn)策劃
    9. 教學課件 >
      教學課件
      幼兒教育 小學教育 初中教育 高中教育 職業(yè)教育 成人教育 高等教育 考研資源 試題真題 作業(yè)習題 課后答案 綜合教學
    10. 土木建筑 >
      土木建筑
      專項施工 應急預案 建筑規(guī)范 工藝方案 技術交底 施工表格 圖片圖集
    11. 課程導學 >
      課程導學
      醫(yī)學綜合 中醫(yī)養(yǎng)生 醫(yī)學研究 身心發(fā)展 醫(yī)學試題 影像醫(yī)學 醫(yī)院辦公 外科醫(yī)學 老年醫(yī)學 內(nèi)科醫(yī)學 婦產(chǎn)科 神經(jīng)科 醫(yī)學課件 眼鼻喉科 皮膚病科 腫瘤科 兒科醫(yī)學 康復醫(yī)學 全科醫(yī)學 護理學科 針灸學科 重癥學科 病毒學科 獸醫(yī) 藥學
      • 簡介:BIODRUGS20082213744NOVELTHERAPEUTICSTRATEGIES11738804/08/00010037/4800/0?2008ADISDATAINFORMATIONBVALLRIGHTSRESERVEDFIBROBLASTGROWTHFACTOR21ASATHERAPEUTICAGENTFORMETABOLICDISEASESALEXEIKHARITONENKOVANDARMENBSHANAFELTBIOTECHOLOGYDISCOVERYRESEARCH,LILLYRESEARCHLABORATORIES,LILLYCORPORATECENTER,INDIANAPOLIS,INDIANA,USACONTENTSABSTRACT371THEROLEOFFIBROBLASTGROWTHFACTORSFGFSINTHEREGULATIONOFMETABOLICPROCESSES372OVERVIEWOFFGF21ANDITSINVITROEFFECTS383FGF21INVIVOPHARMACOLOGY394INSIGHTSINTOFGF21MECHANISMOFACTION405CONCLUSION43FIBROBLASTGROWTHFACTORFGF21ISAUNIQUEMEMBEROFTHEFGFFAMILY,WITHSEVERALMOLECULARCHARACTERISABSTRACTTICSTHATDIFFERFROMCLASSICALFGFSANDEXHIBITINGAPHARMACOLOGICPROFILETHATINCLUDESAVARIETYOFMETABOLICRESPONSESINVITROANDWHENTESTEDINVIVOINANIMALMODELSFGF21REPRESENTSANOVELANDATTRACTIVETHERAPEUTICAGENTFORTYPE2DIABETESMELLITUS,BECAUSEOFITSABILITYTOMODULATEDISEASEPHENOTYPEINPRECLINICALSETTINGSWITHOUTINDUCINGANYAPPARENTADVERSEEFFECTSALTHOUGHFGF21WASDISCOVEREDRELATIVELYRECENTLY,THEUNDERSTANDINGOFITSBIOLOGYANDTHERAPEUTICUTILITYISRAPIDLYEVOLVINGANUMBEROFKEYMETABOLICALLYLINKEDMOLECULESANDPATHWAYSHAVEBEENSUGGESTEDTOBEINVOLVEDINTHEMECHANISMOFACTIONOFFGF21,DEPENDINGONTHESPECIFICTARGETTISSUE/ORGANFURTHERRESEARCHINTOTHESEMECHANISMSSHOULDLEADTOIMPORTANTADVANCESINTHEUNDERSTANDINGOFFGF21BIOLOGYANDPAVETHEWAYFORNOVELTHERAPEUTICSTRATEGIESTHESPECIFICSOFFGF21ACTIVITIESBOTHINCELLCULTUREANDINVIVO,ITSPOTENTIALASATARGETFORDIABETES,ANDINSIGHTSINTOTHEMOLECULARMECHANISMSOFFGF21METABOLICACTIONSWILLBEDISCUSSEDINTHISREVIEW1THEROLEOFFIBROBLASTGROWTHFACTORSFGFSINRODENTS,RESPECTIVELY8,9WHENTESTEDINMICE,FGF19PROVIDESTHEREGULATIONOFMETABOLICPROCESSESRESISTANCETOOBESITYANDINSULINDESENSITIZATION10,11ANOTHERMEMBEROFTHEFGFFAMILY,FGF23,ISAKEYPLAYERINTHEREGULAFIBROBLASTGROWTHFACTORSFGFSANDTHEIRCORRESPONDINGRETIONOFPHOSPHATEANDCALCIUMMETABOLISM12,13LIKEWISE,THECEPTORSFGFRSHAVEBEENPRIMARILYASSOCIATEDWITHTHEPROCESSESOFDEVELOPMENT,TRANSFORMATION,ANDANGIOGENESIS14HOWOVEREXPRESSIONOFADOMINANTNEGATIVEFORMOFFGFR1INPANCREEVER,OVERTHELASTDECADE,NEWDATAHAVEEMERGEDSHOWINGTHATATICΒCELLSLEADSTODIABETESMELLITUSINMICE14FGFR2APPEARSTOFGF/FGFRMEDIATEDPATHWAYSMAYPLAYIMPORTANTROLESINDEFINBEAKEYMOLECULEINTHEPROCESSOFPANCREATICDEVELOPMENT1517INGANDREGULATINGFUNCTIONSOFENDOCRINERELEVANTTISSUESANDFGFR3ISACRITICALPLAYERINBONE,18WHEREASFGFR4HASBEENORGANS,ASWELLASMODULATINGVARIOUSMETABOLICPROCESSESFORIMPLICATEDINCHOLESTEROLMETABOLISMANDBILEACIDSYNTHESIS19EXAMPLE,FGF10ANDFGF16PLAYIMPORTANTROLESINADIPOCYTEANDTHEMETABOLICROLESOFFGF/FGFRARESTILLNOTPRECISELYDEFINEDPANCREATICBIOLOGY,57ANDFGF19ANDITSMOUSEORTHOLOGFGF15,REGULATECHOLESTEROLANDBILEACIDMETABOLISMINHUMANSANDANDARECURRENTLYUNDERINTENSEINVESTIGATIONFGF21ANDMETABOLICDISEASES39INDUCESUPREGULATIONOFPPARΓPROTEINALTHOUGHITISCURRENTLYINCIDENCEOFHEPATOCELLULARCARCINOMASINFGF21TRANSGENICMICEUNCLEARWHATPARTICULARIMPACTEACHOFTHESEEFFECTSHASONGLUCOSEAT12MONTHSOFAGEWASSIMILARTOTHATINCONTROLANIMALSTHUS,IFTRANSPORT,THESEDATAREVEALPOTENTIALSYNERGYINTHEACTIONSBEFGF21NEGATIVELYREGULATESCHEMICALLYINDUCEDHEPATOCARCITWEENTHESETWOREGULATORSOFGLUCOSEHOMEOSTASIS,FGF21ANDNOGENESIS,ITISLIKELYTOINTERFEREWITHDISEASEPROGRESSIONATITSPPARΓ31EARLYSTAGES24RECENTLY,ANOTHERLINEOFFGF21TRANSGENICMICEONAC57BL/6JBACKGROUNDHASBEENDESCRIBED26THESEANIMALSHAD50–1503FGF21INVIVOPHARMACOLOGYTIMESHIGHERLEVELSOFFGF21MRNAINTHELIVERTHANCONTROLANIMALS,ANDHADLOWEREDLEVELSOFSERUMCHOLESTEROL,TRITHEINVIVOBIOACTIVITYOFFGF21HASBEENOBSERVEDUSINGGLYCERIDES,GLUCOSEANDINSULININDICATIVEOFTHEIMPROVEDLIPIDNUMEROUSBIOMARKERSTHATILLUSTRATETHEEFFECTSOFFGF21ACTIONSANDGLYCEMICMETABOLISM,ANDAMELIORATEDINSULINRESISTANCE,INABROADRANGEOFANIMALSTUDIESCOVERINGAVARIETYOFDISEASECONSISTENTWITHPREVIOUSLYPUBLISHEDDATA20FGF21TRANSGENICMODELS20,2326,35MICEWEREALSOFOUNDTOHAVEELEVATEDSERUMLEVELSOFΒHYDROXYTHECONSEQUENCESOFENFORCEDEXPRESSIONOFHUMAN20ANDBUTYRATE,SUGGESTINGTHEINDUCTIONOFKETOGENESIS,ASWELLASHAVMOUSEFGF2123,26HAVEBEENEVALUATEDINTRANSGENICMICE20,24,26INGADIPOCYTESOFSMALLERSIZE,INCREASEDLIPASEEXPRESSIONINWHITEFGF21TRANSGENICANIMALSAPPEARVIABLE,NORMALATBIRTH,ANDADIPOSETISSUEANDELEVATEDSERUMLEVELSOFFREEFATTYACIDS,ALLESSENTIALLYINDISTINGUISHABLEFROMTHEIRWILDTYPELITTERMATESNOEVOCATIVEOFTHEINDUCTIONOFLYPOLYSIS26IMPORTANTLY,ASURINETICEABLY,THEYDONOTPOSSESSSIGNSOFNEOPLASIA,TUMORS,ORANYCONCENTRATIONSOFADRENALINEANDNORADRENALINEWEREREDUCEDINOTHEROVERTABNORMALITIESTHROUGHOUTTHEIRLIFESPAN,ASDEMONSTRAFGF21TRANSGENICANIMALS,FGF21DOESNOTAPPEARTOSTIMULATETEDBYEXTENSIVEMORPHOLOGICANDHISTOLOGICANALYSES20,23THUS,LIPOLYSISTHROUGHASYSTEMICINCREASEINCATECHOLAMINES26SURPROLONGEDEXPOSUREOFMICETOFGF21DOESNOTLEADTOCARCINOGENPRISINGLY,THESEFGF21TRANSGENICMICEWEREALSOREPORTEDTOHAVEICEVENTSNEVERTHELESS,ASPECIFICPHENOTYPEOFFGF21TRANSGENIC1–2oCLOWERCOREBODYTEMPERATURES,REDUCEDLOCOMOTORACTIVITY,MICEWASREVEALEDUPONAVARIETYOFCHALLENGESANDENHANCEDTORPORDURING24HOURFASTINGCOMPAREDWITHTHEIRC57BL/6MICEOVEREXPRESSINGHUMANFGF21FROMTHELIVERCONTROLLITTERMATES26ALTHOUGHINTRIGUING,THELATTEROBSERVATIONSCIRCULATINGLEVELSOF70–150NG/MLWEREEVALUATEDFORCHANGESHAVENOTBEENREPORTEDBYOTHERS20,24AND,THEREFORE,NEEDTOBEINMETABOLICPARAMETERS20WHENFEDAHIGHFAT,HIGHCARBOHYEXPLOREDFURTHERDRATEHFHCDIETFOR15WEEKS,FGF21TRANSGENICMICEWEREADENOVIRUSMEDIATEDKNOCKDOWNOFFGF21WITHSHORTHAIRPINRESISTANTTOWEIGHTGAINANDFATACCUMULATION,DESPITEANINCREASEDRNASHFGF21INMICELEDTOASUBSTANTIALDECREASEINCIRCULATCALORICINTAKECONSISTENTWITHLOWADIPOSITY,THELEVELSOFLEPTININGFGF21LEVELSANDRESULTEDINSERIOUSMETABOLICABNORMALITIES,WERENOTICEABLYREDUCED,ASWELLASTHOSEOFGLUCAGONIMPORTANTSUCHASFATTYLIVER,SEVEREHYPERTRIGLYCERIDEMIAPREDOMINANTLYASLY,THESEEFFECTSWERENOTASSOCIATEDONLYWITHTHEHFHCDIET,ASARESULTOFTHEINCREASEINCHYLOMICRON/VERYLOWDENSITYLIPOTHEYWEREALSOOBSERVEDINAGEDFGF21TRANSGENICMICEONAPROTEINFRACTION,ASIGNIFICANTELEVATIONINSERUMFREEFATTYACIDSNORMALCHOWDIETAT9MONTHSOFAGE,THEYWEIGHEDSIGNIFICANTLYANDTOTALCHOLESTEROL,ANDAREDUCTIONINSERUMKETONES23IMPORLESS,HADLOWERFASTINGGLUCOSELEVELS,LESSTOTALANDLIVERFAT,MORETANTLY,THESECHANGESWEREAPPARENTONLYINANIMALSFEDAHIGHFATBROWNADIPOCYTES,ANDSHOWEDIMPROVEDGLUCOSECLEARANCEANDDIETANDNOTONANORMALCHOWDIETTHISCORRELATESWITHADRAMATICINSULINSENSITIVITYCOMPAREDWITHCONTROLANIMALS20ELEVATIONINTHEENDOGENOUSEXPRESSIONOFFGF21INANIMALSONAANALYSISOFFVBMICEWITHLIVERSPECIFICOVEREXPRESSIONOFKETOGENICDIET,ANDPROVIDESFURTHEREVIDENCETHATTHEOUTCOMESOFMOUSEFGF21CONFIRMEDTHEABSENCEOFNEOPLASIASORTUMORS24SHFGF21EXPERIMENTSAREINDEEDARESULTOFADIRECTATTENUATIONOFMOREOVER,WHENCOMPAREDWITHCONTROLANIMALS,NOCHANGEWASENDOGENOUSFGF21EXPRESSION/FUNCTION23OBSERVEDINTHEINCORPORATIONOFBROMODEOXYURIDINEBRDUINTOTHELIVERSOFFGF21TRANSGENICMICEAFTERPARTIALHEPATECTOMYORSYSTEMICADMINISTRATIONOFFGF21INRODENTSVIASUBCUTANEOUSCCL4INSULT,SUGGESTINGTHATFGF21ISUNLIKELYTOPLAYAROLEINAINJECTIONSORTHROUGHCONSTANTINFUSIONLEADSTOAVARIETYOFMETACOMPENSATORYLIVERRESTORATIONPROCESSUNEXPECTEDLY,FORCEDEXBOLICCONSEQUENCESFGF21EFFECTIVELYLOWERSFEDANDFASTEDPRESSIONOFFGF21MARKEDLYREDUCESTUMORINCIDENCE,MEASUREDPLASMAGLUCOSELEVELS,STIMULATESGLUCOSEDISPOSAL,ANDINCREASESBYTHEFREQUENCYOFDIETHYLNITROSAMINEINDUCEDADENOMASANDTHEINSULINSENSITIVITYINORALGLUCOSETOLERANCETESTS20IMPORTANTLY,TIMINGOFTHEIRFIRSTAPPEARANCE24HOWEVER,ALTHOUGHFGF21THEFGF21GLUCOSELOWERINGEFFECTSARELONGLASTING,ASTHEYAPPEARSTODELAYTHEPROCESSOFTUMORINITIATIONINTHELIVER,THEPERSISTFORATLEAST24HOURSFOLLOWINGTHECESSATIONOFFGF21?2008ADISDATAINFORMATIONBVALLRIGHTSRESERVEDBIODRUGS2008221
        下載積分: 10 賞幣
        上傳時間:2024-03-13
        頁數(shù): 8
        6人已閱讀
        ( 4 星級)
      • 簡介:CEFOSELISCFSL,AFOURTHGENERATIONPARENTERALCEPHALOSPORIN,HASBEENMARKETEDINJAPANSINCESEPTEMBER1998INDECEMBER1998,WARNINGSOFCENTRALNERVOUSSYSTEMCNSADVERSEEFFECTSSUCHASSEIZURESANDCONFUSIONALSTATESWEREADDEDTOTHELABELINGOFCFSLINMANYCASES,THESEADVERSEEFFECTSWEREOBSERVEDINPATIENTSWHOWEREELDERLYAND/ORHADRENALFAILURETHEREFORERENALFAILUREISCONSIDEREDASONEOFTHERISKFACTORSFORNEUROTOXICITYOFCFSLSINCECFSLISMAINLYELIMINATEDBYRENALEXCRETION,1RENALFAILUREWOULDBEASSOCIATEDWITHINCREASEDSERUMCONCENTRATIONSOFCFSLONTHEOTHERHAND,ITISSTILLUNKNOWNWHETHERRENALFAILURECANALTERTHEPHARMACODYNAMICSOFCFSLINDUCEDSEIZURESDRUGADMINISTRATIONCANBEDIVIDEDINTOTWOPHASESAPHARMACOKINETICPHASEINWHICHDOSE,DOSAGEFORM,FREQUENCY,ANDROUTEOFADMINISTRATIONARERELATEDTODRUGCONCENTRATION–TIMERELATIONSHIPSINTHEBODYANDAPHARMACODYNAMICPHASEINWHICHTHECONCENTRATIONOFDRUGATTHESITESOFACTIONISRELATEDTOTHEMAGNITUDESOFTHEEFFECTSPRODUCED2THEPATHOPHYSIOLOGICSTATUSOFPATIENTSCANAFFECTBOTHTHEPHARMACOKINETICSANDTHEPHARMACODYNAMICSOFADRUGOURKNOWLEDGEOFTHEEFFECTSOFDISEASEONTHEPHARMACOKINETICSOFADRUGCANNOTBEUSEDTOOPTIMIZETHEDRUGDOSAGEOFAPATIENTWITHOUTINFORMATIONONDISEASEEFFECTSONTHEPHARMACODYNAMICS3THEREFOREITISIMPORTANTTODISTINGUISHTHEEFFECTSOFDISEASEONTHEPHARMACOKINETICSFROMTHOSEONTHEPHARMACODYNAMICSDANHOFANDLEVY3REPORTEDANEXPERIMENTALSTRATEGYTOASSESSTHEEFFECTSOFDISEASEANDOTHERVARIABLESONTHEPHARMACODYNAMICSOFDRUGSWITHCNSACTIVITYTHEEFFECTSOFEXPERIMENTALRENALFAILUREONTHEPHARMACODYNAMICSOFCNSSTIMULANTDRUGSSUCHASTHEOPHYLLINE,4PENTYLENTETRAZOLE,5ANDCIMETIDINE6WEREINVESTIGATEDPREVIOUSLYTHEREHAVEBEENCLINICALCASEREPORTSOFSEIZURESCAUSEDBYVARIOUSBLACTAMANTIBIOTICSSUCHASPENICILLIN,7CEFAZOLINE,8AMPICILLIN,9ANDIMIPENEM10HOWEVER,TOOURKNOWLEDGE,THEREHAVEBEENNOREPORTSTHATCLARIFIEDTHEEFFECTOFRENALFAILUREONTHEPHARMACODYNAMICSOFBLACTAMANTIBIOTICINDUCEDSEIZURESTOASSURESAFEANDEFFECTIVEANTIBIOTICDRUGTHERAPY,ITMUSTBEDETERMINEDIFRENALFAILURECANCHANGETHERELATIONSHIPBETWEENTHECONCENTRATIONANDINTENSITYOFPHARMACOLOGICACTIVITYOFDRUGSTHEPRESENTSTUDYWASDESIGNEDTODETERMINE1THESUITABILITYOFTHERATASANANIMALMODELOFCFSLINDUCEDSEIZURES2THESAMPLINGSITEWHERECFSLCONCENTRATIONSREFLECTTHEDRUGCONCENTRATIONATTHESITEOFNEUROTOXICACTIONAND3THEEFFECTOFRENALFAILUREONTHEPHARMACODYNAMICSOFCFSLINDUCEDSEIZURESMATERIALSANDMETHODSANIMALSMALEWISTARRATSWEIGHING240TO300GWEREUSEDINTHISINVESTIGATIONTHERATSHADANINDWELLINGCANNULAIMPLANTEDINTHELEFTJUGLARVEINUNDERLIGHTETHERANESTHESIAONEDAYBEFORETHEEXPERIMENTANDTHEYWEREFASTEDUNTILTHECFSLINFUSIONBEGANCHEMICALSCFSLSULFATEWINCEF?FORINFUSIONUSEDFORANIMALEXPERIMENTSWASOBTAINEDFROMFUJISAWAPHARMACEUTICALCO,LTDCEFPIROMESULFATEBROACT?INJECTIONUSEDASANINTERNALSTANDARDWASOBTAINEDFROMSHIONOGICO,LTDALLOTHERCHEMICALSWEREPURCHASEDFROMCOMMERCIALSOURCESANDUSEDWITHOUTFURTHERPURIFICATIONEFFECTOFINFUSIONRATEONTHECONCENTRATIONSOFCFSLINSERUM,BRAIN,ANDCSFATONSETOFMAXIMALSEIZURESCFSLWASINFUSEDTHROUGHTHECANNULAATONEOFTHREEDIFFERENTRATES14,29,OR58G/HINRATSTHEINFUSIONWASSTOPPEDIMMEDIATELYATTHEONSETOFMAXIMALSEIZURESTHERATSWERETHENLIGHTLYANESTHETIZEDWITHETHER,ANDSAMPLESOFCSF,BLOOD,ANDBRAINWEREOBTAINED,INTHATORDERCSFWASOBTAINEDBYCISTERNALPUNCTUREBLOODWASOBTAINEDFROMTHEABDOMINALAORTAANDCENTRIFUGEDTOOBTAINSERUMTHEWHOLEBRAINWASREMOVEDANDTHERIGHTHALFOFTHECEREBRUMWASUSEDFORDRUGASSAYSEPTEMBER2001BIOLPHARMBULL2491049105220011049?TOWHOMCORRESPONDENCESHOULDBEADDRESSEDEMAILYASUHARAMPHAMEDTMDACJP?2001PHARMACEUTICALSOCIETYOFJAPANEFFECTOFEXPERIMENTALRENALFAILUREONTHEPHARMACODYNAMICSOFCEFOSELISINDUCEDSEIZURESINRATSMASASHINAGATAANDMASATOYASUHARADEPARTMENTOFHOSPITALPHARMACY,SCHOOLOFMEDICINE,TOKYOMEDICALANDDENTALUNIVERSITY,1–5–45YUSHIMA,BUNKYOKU,TOKYO113–8519,JAPANRECEIVEDAPRIL17,2001ACCEPTEDJUNE12,2001WEINVESTIGATEDTHEEFFECTOFINFUSIONRATEANDEXPERIMENTALRENALFAILUREONTHEPHARMACODYNAMICSOFCEFOSELISCFSLINDUCEDSEIZURESASANANIMALMODELOFCFSLINDUCEDSEIZURES,MALEWISTARRATSRECEIVEDANINTRAVENOUSINFUSIONOFCFSLATONEOFTHREEDIFFERENTRATES1458G/H/RATUNTILTHEONSETOFMAXIMALSEIZURESWHICHOCCURREDAFTER80TO360MINOFINFUSIONSAMPLESOFCEREBROSPINALFLUIDCSF,BLOODFORSERUM,ANDBRAINWEREOBTAINEDIMMEDIATELYAFTERSTOPPINGINFUSIONOFCSFLTHESERUMCONCENTRATIONOFCFSLATTHEONSETOFSEIZURESINCREASEDWITHINCREASINGINFUSIONRATE,BUTBRAINANDCSFCONCENTRATIONSOFCFSLATTHEONSETOFSEIZURESWERENOTAFFECTEDBYTHEINFUSIONRATEURETERLIGATEDULANDCONTROLRATSRECEIVEDANINTRAVENOUSINFUSIONOFCFSLAT14G/H/RATUNTILTHEONSETOFSEIZURESTHENTHESAMEPROCEDUREASUSEDTODETERMINETHEEFFECTOFINFUSIONRATEONTHECONCENTRATIONSOFCFSLWASCARRIEDOUTRENALFAILUREWASASSOCIATEDWITHASIGNIFICANTDECREASEINTHEAMOUNTOFCFSLREQUIREDTOINDUCESEIZURESSERUM,BRAIN,ANDCSFCONCENTRATIONSOFCFSLINULRATSWERESIGNIFICANTLYLOWERTHANTHOSEINCONTROLRATSTHESERESULTSINDICATETHATTHEEXPERIMENTALSTRATEGYANDANIMALMODELINTHISINVESTIGATIONWOULDBEUSEFULTOASSESSTHEEFFECTSOFDISEASESANDOTHERVARIABLESONTHEPHARMACODYNAMICSOFCFSLINDUCEDSEIZURESANDTHATRENALFAILUREISONEOFTHERISKFACTORSFORNEUROTOXICITYOFCFSLKEYWORDSCEFOSELISRENALFAILURESEIZUREPHARMACODYNAMICSDISCUSSIONDRUGSTHATACTDIRECTLYANDREVERSIBLY,HAVENOPHARMACOLOGICALLYACTIVEMETABOLITES,ANDARENOTSUBJECTTOTHEDEVELOPMENTOFACUTETOLERANCEMAYBEEXPECTEDTOPRODUCETHEIRAPPARENTPHARMACOLOGICEFFECTSWHENTHEIRCONCENTRATIONSATTHESITEOFACTIONREACHANDEXCEEDTHEMINIMUMEFFECTIVECONCENTRATIONWENEEDTODETERMINETHESAMPLINGSITETHATREFLECTSDRUGCONCENTRATIONSINTHESITEOFACTIONBECAUSEITISTECHNICALLYIMPOSSIBLETOMEASUREDRUGCONCENTRATIONSINTHEIMMEDIATEENVIRONMENTOFTHESITEOFACTIONFORTHISPURPOSE,THEDRUGISADMINISTEREDBYCONSTANTRATEINTRAVENOUSINFUSIONATDIFFERENTRATESUNTILTHEONSETOFASUITABLEPHARMACOLOGICENDPOINTANDDRUGCONCENTRATIONINVARIOUSFLUIDSANDTISSUESSERUM,BRAIN,ANDCSFATTHATTIMEAREDETERMINEDSITESATWHICHTHEDRUGCONCENTRATIONATTHEONSETOFACTIONISDEPENDENTONINFUSIONRATETHECONCENTRATIONTENDSTOINCREASEWITHINCREASINGINFUSIONRATECANBECONSIDEREDTOBEINSLOWEQUILIBRIUMWITHTHESITEOFACTIONANYFLUIDORTISSUETHATYIELDSTHESAMEDRUGCONCENTRATIONATONSETOFACTION,INDEPENDENTOFTHERATEOFDRUGADMINISTRATION,MUSTBECONSIDEREDASBEINGIN“INSTANTANEOUS”DISTRIBUTIONEQUILIBRIUMWITHTHESITEOFACTION3THERESULTSOFTHISSTUDYSHOWTHATCFSLCONCENTRATIONINTHESERUMATTHEONSETOFMAXIMALSEIZURESISSIGNIFICANTLYAFFECTEDBYTHERATEOFDRUGINFUSION,WHEREASCFSLCONCENTRATIONSINTHEBRAINANDCSFATTHEPHARMACOLOGICENDPOINTAREINDEPENDENTOFINFUSIONRATETHESERESULTSSUGGESTTHATCFSLEQUILIBRATESSLOWLYBETWEENSERUMANDTHESITEOFACTION,ANDDRUGCONCENTRATIONSINTHEBRAINANDCSFAREMOREAPPROPRIATEINDICESOFTHEDRUGCONCENTRATIONINTHESITEOFACTIONWEALSOINVESTIGATEDTHEEFFECTOFEXPERIMENTALRENALFAILUREONTHEPHARMACODYNAMICSOFCFSLINDUCEDSEIZURESINRATSINTHEPRESENTSTUDY,RENALFAILUREWASASSOCIATEDWITHASIGNIFICANTDECREASEINTHEAMOUNTOFCFSLREQUIREDTOINDUCESEIZURESTHISRESULTSUGGESTSTHATRENALFAILUREISONEOFTHERISKFACTORSFORCFSLINDUCEDSEIZURES,ANDTHISISCONSISTENTWITHRECENTCLINICALFINDINGSOFAHIGHERINCIDENCEOFCFSLINDUCEDNEUROTOXICITYINPATIENTSWITHRENALFAILURE11INADDITION,SERUM,BRAIN,ANDCSFCONCENTRATIONSOFCFSLINULRATSWERESIGNIFICANTLYLOWERTHANTHOSEINCONTROLRATSTHISINDICATESTHATRENALFAILUREISASSOCIATEDWITHCHANGESINTHEPHARMACODYNAMICSOFCFSLINDUCEDSEIZURESRENALFAILURECOULDCHANGETHEPHARMACOKINETICSOFCFSLBECAUSECFSLISMAINLYELIMINATEDBYRENALEXCRETION1THEPERMEABILITYOFTHEBLOODCSFBARRIERMAYBEINCREASEDASREFLECTEDBYINCREASEDPROTEINCONCENTRATIONINTHECSFIFRENALFAILUREAFFECTEDONLYTHEPHARMACOKINETICSOFCFSLAND/ORTHEPERMEABILITYOFCFSLATTHEBLOODCSFBARRIER,THEREWOULDBENODIFFERENCESINTHECFSLCONCENTRATIONINTHEBRAINANDCSFATTHEONSETOFSEIZURESBETWEENCONTROLANDULRATSINTHISSTUDY,HOWEVER,ULRATSHADLOWERBRAINANDCSFCONCENTRATIONSOFCFSLATTHEONSETOFSEIZURESCOMPAREDWITHTHECORRESPONDINGRESULTSINCONTROLRATSTHISINDICATESTHATTHECAUSEOFTHECHANGEINDRUGEFFECTWITHRENALFAILUREISNOTONLYTHEDELAYINCFSLELIMINATIONANDTHEINCREASEDPERMEABILITYOFCFSLATTHEBLOODCSFBARRIERBUTALSOTHEINCREASEDCNSSENSITIVITYTOCFSLINDUCEDSEIZURESTHEEFFECTSOFEXPERIMENTALRENALFAILUREONTHEPHARMACODYNAMICSOFOTHERCNSACTIVEDRUGSWEREINVESTIGATEDPREVIOUSLY46,12,13RAMZANANDLEVY4REPORTEDTHATTHETHEOPHYLLINECONCENTRATIONSINTHESERUM,BRAIN,ANDCSFATTHEONSETOFMAXIMALSEIZURESINRATSWITHRENALFAILUREBYURETERLIGATIONWERELOWERTHANTHOSEINCONTROLRATSHOFFMANANDLEVY14REPORTEDTHATTHEPOTENTIATIONOFTHECONVULSIVEEFFECTOFTHEOPHYLINEINRATSWITHRENALFAILUREWASCOUNTERACTEDBYORALADMINISTRATIONOFACTIVATEDCHARCOALTHATPRESUMABLYINTERRUPTSTHECYCLINGOFTHEENDOGENOUSSUBSTANCESBETWEENBLOODANDTHEGASTROINTESTINALTRACTTHESEINDICATETHATCHANGESINDRUGEFFECTSUNDERRENALIMPAIRMENTMAYBEDUETO,ATLEASTINPART,ANINCREASEINLEVELSOFONEORMOREENDOGENOUSSUBSTANCESTHATALTERTHEPHARMACOLOGICALEFFECTSOFCERTAINDRUGSINUREMICRATSTHEUREMICBLOODAPPARENTLYCONTAINSELEVATEDCONCENTRATIONSOFONEORMOREENDOGENOUSSUBSTANCES,THESOCALLEDUREMICTOXINS,ANDTHESERETAINEDSUBSTANCESPROBABLYPLAYAMAJORROLEASTOXINSINTHEPATHOGENESISOFUREMIA,EITHERWORKINGSINGLYORINCOMBINATION15GUANIDINOCOMPOUNDSAREBELIEVEDTOBETOXICAGENTSINPATIENTSWITHRENALINSUFFICIENCYGAMMAGUANIDINOBUTYRICACIDWASSHOWNTOINDUCETONICANDCLONICSEIZURESFOLLOWINGINTRACISTERNALINJECTIONINRABBITS16DEDEYNETALREPORTEDTHATGUANIDINOCOMPOUNDSWEREFOUNDTOBEINCREASEDINTHESERUMANDCSFOFUREMICPATIENTS17ANDGUANIDINOSUCCINICACIDINDUCEDBEHAVIORALCONVULSIONSAFTERINTRAPERITONEALINJECTIONINMICE18INADDITION,FOURGUANIDINOCOMPOUNDSGUANIDINOSUCCINICACID,CREATININE,GUANIDINE,ANDMETHYLGUANIDINEWERESHOWNTOINHIBITGAMMAAMINOBUTYRICACIDANDGLYCINERESPONSESONMOUSENEURONSINCELLCULTURE19THESESUGGESTTHATGUANIDINOCOMPOUNDSCANCONTRIBUTETOINCREASEDNEUROTOXICACTIONOFCERTAINDRUGSINUREMIAWEUSEDULRATSASAMODELOFRENALFAILUREINTHISSTUDYRAMZANANDLEVY5REPORTEDTHATTHEEFFECTOFIMPAIREDRENALFUNCTIONONTHECONVULSANTACTIVITYOFPENTYLENTETRAZOLINULRATSWASDIFFERENTFROMTHATINURANYLNITRATETREATEDRATSFURTHERINVESTIGATIONUSINGMORETHANONEEXPERIMENTALMODELOFDISEASEISTHUSWARRANTEDINCONCLUSION,RENALFAILUREISASSOCIATEDWITHINCREASEDCNSSENSITIVITYTOCFSLINDUCEDSEIZURES,ANDTHEEXPERIMENTALSTRATEGYANDANIMALMODELINTHISINVESTIGATIONWOULDBEUSEFULTOASSESSTHEEFFECTSOFDISEASEANDOTHERVARIABLESONTHEPHARMACODYNAMICSOFCFSLINDUCEDSEIZURESACKNOWLEDGMENTTHISWORKWASSUPPORTEDINPARTBYAGRANTINAIDFORSCIENTIFICRESEARCHCFROMTHEJAPANSOCIETYFORTHEPROMOTIONOFSCIENCEREFERENCES1SAKAMOTOH,HATANOK,HIGASHIY,MINEY,NAKAMOTOS,TAWARAS,KAMIMURAT,JANTIBIOT,46,1201301
        下載積分: 10 賞幣
        上傳時間:2024-03-13
        頁數(shù): 4
        9人已閱讀
        ( 4 星級)
      • 簡介:中文中文2845字出處出處CONTROLENGINEERINGPRACTICE,2000,83253258畢業(yè)設計(論文)畢業(yè)設計(論文)譯文及原稿譯文題目基于接收機的一種新差分GPS修正原稿題目ANEWMETHODOFGENERATINGDIFFERENTIALGPSCORRECTIONS原稿出處WWWELSEVIERCOM/LOCATE/CONENGPRAC圖1圖2GPS提供經(jīng)度,緯度,高度,時間,航線,和速度。GPS的水平精度是近100米至156米高度,時間為340納秒在世界任何地方和任何天氣條件下。
        下載積分: 10 賞幣
        上傳時間:2024-03-16
        頁數(shù): 10
        11人已閱讀
        ( 4 星級)
      • 簡介:附錄附錄一外文原文TEMPERATURECONTROLUSINGAMICROCONTROLLERANINTERDISCIPLINARYUNDERGRADUATEENGINEERINGDESIGNPROJECTJAMESSMCDONALDDEPARTMENTOFENGINEERINGSCIENCETRINITYUNIVERSITYSANANTONIO,TX78212ABSTRACTTHISPAPERDESCRIBESANINTERDISCIPLINARYDESIGNPROJECTWHICHWASDONEUNDERTHEAUTHOR’SSUPERVISIONBYAGROUPOFFOURSENIORSTUDENTSINTHEDEPARTMENTOFENGINEERINGSCIENCEATTRINITYUNIVERSITYTHEOBJECTIVEOFTHEPROJECTWASTODEVELOPATEMPERATURECONTROLSYSTEMFORANAIRFILLEDCHAMBERTHESYSTEMWASTOALLOWENTRYOFADESIREDCHAMBERTEMPERATUREINAPRESCRIBEDRANGEANDTOEXHIBITOVERSHOOTANDSTEADYSTATETEMPERATUREERROROFLESSTHAN1DEGREEKELVININTHEACTUALCHAMBERTEMPERATURESTEPRESPONSETHEDETAILSOFTHEDESIGNDEVELOPEDBYTHISGROUPOFSTUDENTS,BASEDONAMOTOROLAMC68HC05FAMILYMICROCONTROLLER,AREDESCRIBEDTHEPEDAGOGICALVALUEOFTHEPROBLEMISALSODISCUSSEDTHROUGHADESCRIPTIONOFSOMEOFTHEKEYSTEPSINTHEDESIGNPROCESSITISSHOWNTHATTHESOLUTIONREQUIRESBROADKNOWLEDGEDRAWNFROMSEVERALENGINEERINGDISCIPLINESINCLUDINGELECTRICAL,MECHANICAL,ANDCONTROLSYSTEMSENGINEERING1INTRODUCTIONTHEDESIGNPROJECTWHICHISTHESUBJECTOFTHISPAPERORIGINATEDFROMAREALWORLDAPPLICATIONAPROTOTYPEOFAMICROSCOPESLIDEDRYERHADBEENDEVELOPEDAROUNDANOMEGATMMODELCN390TEMPERATURECONTROLLER,ANDTHEOBJECTIVEWASTODEVELOPACUSTOMTEMPERATURECONTROLSYSTEMTOREPLACETHEOMEGASYSTEMTHEMOTIVATIONWASTHATACUSTOMCONTROLLERTARGETEDSPECIFICALLYFORTHEAPPLICATIONSHOULDBEABLETO2PROBLEMSTATEMENTTHEBASICIDEAOFTHEPROJECTISTOREPLACETHERELEVANTPARTSOFTHEFUNCTIONALITYOFANOMEGACN390TEMPERATURECONTROLLERUSINGACUSTOMDESIGNEDSYSTEMTHEAPPLICATIONDICTATESTHATTEMPERATURESETTINGSAREUSUALLYKEPTCONSTANTFORLONGPERIODSOFTIME,BUTIT’SNONETHELESSIMPORTANTTHATSTEPCHANGESBETRACKEDINA“REASONABLE”MANNERTHUSTHEMAINREQUIREMENTSBOILDOWNTOALLOWINGACHAMBERTEMPERATURESETPOINTTOBEENTERED,DISPLAYINGBOTHSETPOINTANDACTUALTEMPERATURES,ANDTRACKINGSTEPCHANGESINSETPOINTTEMPERATUREWITHACCEPTABLERISETIME,STEADYSTATEERROR,ANDOVERSHOOTALTHOUGHNOTEXPLICITLYAPARTOFTHESPECIFICATIONSINTABLE1,ITWASCLEARTHATTHECUSTOMERDESIREDDIGITALDISPLAYSOFSETPOINTANDACTUALTEMPERATURES,ANDTHATSETPOINTTEMPERATUREENTRYSHOULDBEDIGITALASWELLASOPPOSEDTO,SAY,THROUGHAPOTENTIOMETERSETTING3SYSTEMDESIGNTHEREQUIREMENTSFORDIGITALTEMPERATUREDISPLAYSANDSETPOINTENTRYALONEAREENOUGHTODICTATETHATAMICROCONTROLLERBASEDDESIGNISLIKELYTHEMOSTAPPROPRIATEFIGURE2SHOWSABLOCKDIAGRAMOFTHESTUDENTS’DESIGN
        下載積分: 10 賞幣
        上傳時間:2024-03-15
        頁數(shù): 21
        9人已閱讀
        ( 4 星級)
      • 下載積分: 10 賞幣
        上傳時間:2024-03-15
        頁數(shù): 18
        11人已閱讀
        ( 4 星級)
      • 簡介:畢業(yè)設計(論文)外文文獻譯文及原文學生生王波波王波波學號號200705010322200705010322院(系)(系)機電工程學院機電工程學院專業(yè)業(yè)機械設計制造及其自動化機械設計制造及其自動化指導教師指導教師周明貴周明貴2011年5月20日2SHIMBO報道,在典型的結(jié)構成型工藝另一種微孔發(fā)泡過程中注塑機,使用了一個預塑式注塑機被用來塑化螺柱塞聚合物,是用來注入聚合物進入模具腔,另一個替代方案泡沫注射成型工藝是在發(fā)達的德國亞琛的一個系統(tǒng),在這個系統(tǒng)中,氣體注射在一個特別設計的噴油嘴,它安裝在塑化單元之間的,可對噴嘴關閉的常規(guī)射出成型機。此外,它達到更好的分散性之氣,靜態(tài)混合元素被安裝之間的氣體噴油嘴和關閉噴嘴。這項技術后來為商業(yè)化專利。在2006年,有人提出了一個結(jié)構,經(jīng)過在先進的高慶宇發(fā)泡成型技術的基礎上,預塑式注射機傳統(tǒng)的結(jié)構發(fā)泡技術這樣就提高了注入氣體會完全溶解在聚合物。由一個強化技術的齒輪油泵及附加蓄能器使聚合物/氣體混合物形成一步連續(xù)不斷的成型操作。換句話說,更新的設計完全解耦,氣體溶解步驟的注塑操作使用一個主驅(qū)動泵。這一先進的結(jié)構發(fā)泡的細節(jié)技術概述在下一節(jié)。3先進的成型結(jié)構先進的成型機。經(jīng)過先進的發(fā)泡成型機器這種技術促進統(tǒng)一的氣體色散和完整或?qū)嵸|(zhì)溶解在聚合物熔體,盡管是穩(wěn)定成型工藝。但是它認識到連續(xù)成型行為不可避免地引起不一致的氣體充填、這種結(jié)構使得流動但是聚合物熔體和天然氣是連續(xù)的即不停止在注射時期。圖1圖2
        下載積分: 10 賞幣
        上傳時間:2024-03-12
        頁數(shù): 16
        5人已閱讀
        ( 4 星級)
      • 簡介:英文文獻
        下載積分: 10 賞幣
        上傳時間:2024-03-15
        頁數(shù): 15
        7人已閱讀
        ( 4 星級)
      • 簡介:1本科畢業(yè)論文外文翻譯外文題目EXPORTSOFHIGHTECHNOLOGYPRODUCTSFROMDEVELOPINGCOUNTRIESISITREALORASTATISTICALARTIFACT出處2000UNU/INTECH,DISCUSSIONPAPERS作者SUNILMANI原文EXPORTSOFHIGHTECHNOLOGYPRODUCTSFROMDEVELOPINGCOUNTRIESISITREALORASTATISTICALARTIFACTSUNILMANIMAY2000ABSTRACTTHISPAPERFIRSTDEVELOPSACONSISTENTTIMESERIESDATAONTHEEXPORTSOFHIGHTECHNOLOGYPRODUCTSFROMESSENTIALLYTHEDEVELOPINGCOUNTRIESANANALYSISOFTHEDATASHOWSTHATDEVELOPINGCOUNTRIESAREINCREASINGLYBECOMINGEXPORTERSOFMANUFACTUREDPRODUCTSASAGAINSTPRIMARYPRODUCTSINTHEPASTSECONDTHEWORLDTRADEISINCREASINGLYBECOMINGATRADEINHIGHTECHPRODUCTSWHATISMORESTRIKINGISTHESIGNIFICANTINCREASEOFTHETECHNOLOGYCONTENTOFEXPORTSBYDEVELOPINGCOUNTRIESVERYNEARLYAQUARTEROFTHEEXPORTSFROMDEVELOPINGCOUNTRIESISNOWINHIGHTECHPRODUCTSTHIRD,THESHAREOFDEVELOPINGCOUNTRIESINHIGHTECHEXPORTSHAVESHOWNDRAMATICINCREASESITHASINCREASEDFROMABOUT8PERCENTIN1988TOABOUT23PERCENTBY1997BUTTHEREISCONSIDERABLECONCENTRATIONOFITINAFEWCOUNTRIESTHEPAPERTHENSEEKSTOEXPLAINWHETHERTHESEDEVELOPINGCOUNTRIESAREREALEXPORTERSOFHIGHTECHPRODUCTSORNOTTHISISACCOMPLISHEDBYACAREFULEXAMINATIONOFTHEDEGREEOFPRODUCTSPECIALISATIONBYBOTHDEVELOPEDANDDEVELOPINGCOUNTRIES,BYEXAMININGTHEIRRECORDWITHRESPECTTOPATENTINGANDFINALLYBYANALYSINGCERTAININDICATORSOFHIGHTECHCOMPETITIVENESSTHEPAPERCONCLUDESBYPRESENTINGACASESTUDYOFALEADINGHIGHTECHEXPORTERFROMTHEDEVELOPINGWORLD1DEFINITIONOFHIGHTECHNOLOGYECONOMISTSHAVEBEENATTEMPTINGTOMEASURETHETECHNOLOGYCONTENTOFWORLDTRADETHISISACCOMPLISHEDINTERMSOFTHETECHNOLOGYEMBODIEDINPRODUCTSTHATAREEXPORTEDFROMACOUNTRYADMITTEDLYITISADIFFICULTEXERCISEANDNOMETHODISFOOLPROOFANDPERFECTTHEGREATESTDIFFICULTYISINCLASSIFYINGPRODUCTSACCORDINGTOTHETECHNOLOGYCONTENTEMBODIEDINITSEVERALATTEMPTSINTHISDIRECTIONHAVEBEENMADEINTHEPASTINTHEFOLLOWINGIUNDERTAKEAQUICKREVIEWOFTHEMETHODOLOGIESTHISISESSENTIAL,ASIWILLATTEMPTTOSHOWTHATDEPENDINGONTHEDEFINITIONOFHIGHTECHNOLOGYTHATISEMPLOYED,ITISPOSSIBLETOGETSIGNIFICANTLYDIFFERENTRESULTSTHEFIRSTSYSTEMATICEFFORTINTHISDIRECTIONWASBYDAVIS1982HEDEFINEDHIGHTECHNOLOGY3ALLTHECOUNTRIESACCORDINGTOTHEIRHIGHTECHEXPORTINTENSITY,ANDTHENTHERANKINGISENTIRELYDIFFERENTTABLE8TABLE7CONCENTRATIONINEXPORTSOFHIGHTECHPRODUCTSBASEDONABSOLUTEVALUESSHAREOFTHETOP10HIGHTECHEXPORTINGCOUNTRIESINPERCENTCONCENTRATIONWITHINEACHCATEGORYINPERCENTSHAREOFTOP5DEVELOPEDCOUNTRIESSHAREOFTOP5DEVELOPINGCOUNTRIES19886866871989777687199075748619917878821992787685199377768619947775861995767387199674728219977572851998777295NOTETHETOP5DEVELOPEDCOUNTRIESARETHEUS,JAPAN,GERMANY,UKANDFRANCEANDTHETOP5DEVELOPINGCOUNTRIESARESINGAPORE,KOREA,MALAYSIA,CHINAANDMEXICOSOURCEINTECH2000TABLE8RANKINGOFDEVELOPEDANDDEVELOPINGCOUNTRIESACCORDINGTOHIGHTECHEXPORTINTENSITYDEVELOPEDCOUNTRIESDEVELOPINGCOUNTRIESRANKNAMEAVERAGEEXPORTINTENSITYRANKNAMEAVERAGEEXPORTINTENSITY1IRELAND42821SINGAPORE49782USA3192MALAYSIA43133JAPAN25113PHILIPPINES38334UK24964THAILAND22795NETHERLANDS21715KOREA2162NOTESAVERAGEDURINGTHEPERIOD198898MALTA,WHICHHASANAVERAGEEXPORTINTENSITYOF5572PERCENT,ISTHEHIGHESTINTHEWORLDFORTHETIMEBEING,THISHASBEENEXCLUDEDSOURCEINTECH2000ITMAYWELLBETHATSOMEOFTHESECOUNTRIESANDESPECIALLYTHOSEFROMTHEDEVELOPINGWORLDANDPERHAPSIRELANDFROMTHEDEVELOPEDWORLDARENOREALMANUFACTURERSOFHIGHTECHPRODUCTSTHISPOINTWILLBEEXAMINEDINSOMEDETAILINTHELASTSECTION22THECATCHINGUPOFDEVELOPINGCOUNTRIESINHIGHTECHEXPORTS
        下載積分: 10 賞幣
        上傳時間:2024-03-12
        頁數(shù): 16
        10人已閱讀
        ( 4 星級)
      • 簡介:ABSTRACTHONDAHASDEVELOPEDAPOWERTRAINFOR2013SUBCOMPACTCLASSEVSTHISPOWERTRAINHASBOTHHIGHPOWERANDLOWLOSSINORDERTOPROVIDETHEEVWITHBETTERMARKETABILITYTHANEXISTINGEVS,WITHTHEWORLDBESTENERGYEFFICIENCYANDCLASSEXCEEDINGDYNAMICPERFORMANCETOACHIEVETHEENERGYEFFICIENCY,THISPOWERTRAINALSOHASAFUNCTIONOFCOOPERATIVECONTROLWITHANEWLYDEVELOPEDELECTRICALLYOPERATEDSERVOBRAKESYSTEMTOACHIEVETHEHIGHDYNAMICPERFORMANCE,ANEWROTORSHAPEHASBEENINTRODUCEDTOTHEELECTRICMOTOR,ANDTHEPOWERCONTROLUNITPCUISEQUIPPEDWITHAHIGHTHERMALCONDUCTIVITYHEATSINKTHEBATTERYSYSTEMALLOWSHIGHOUTPUTPOWERINACOMPACTSTRUCTUREBECAUSEOFATRIPLEPARALLELMODULEGROUPCONFIGURATIONANDANAIRCOOLINGSYSTEMASARESULTOFTHESEINNOVATIONSINTHEPOWERTRAIN,THEVEHICLEATTAINS82MILESOFDRIVINGRANGEWHILEACHIEVINGWORLDLEADINGENERGYEFFICIENCYOF29KWH/100MILESITALSOHASTHEACCELERATIONPERFORMANCEEQUIVALENTTOATWOLITERGASOLINEDRIVENVEHICLEINTRODUCTIONINRECENTYEARS,ELECTRICVEHICLESHAVEBEENGATHERINGINCREASEDATTENTIONASAMEANSOFELIMINATINGEXHAUSTGASEMISSIONSFROMVEHICLESANDREDUCINGDEPENDENCEONOILINRESPONSETOTHESENEEDS,HONDARELEASED100ELECTRICPOWEREDVEHICLESINCLUDINGTHEEVPLUSELECTRICVEHICLEIN1997ANDTHEFCXCLARITYFUELCELLVEHICLEIN2009,BASEDONTHEEFFORTSOFDEVELOPINGHIGHEFFICIENCYENVIRONMENTALLYFRIENDLYPOWERTRAINSTHEAUTHORSDEVELOPEDAPOWERTRAINFORSUBCOMPACTCLASSEVTHATENABLESTHEVEHICLETOHAVEEXCELLENTENERGYEFFICIENCYANDSUPERIORDYNAMICPERFORMANCE,BYLEVERAGINGHONDASEXPERTISEOFELECTRICPOWERTRAINSANDENERGYMANAGEMENTTECHNOLOGYWITHTHEAIMOFREDUCINGCARBONDIOXIDEEMISSIONANDEFFECTIVELYUSINGALTERNATIVEENERGYSOURCESTHISPAPERPRESENTSADETAILEDEXPLANATIONOFTHELOWLOSSTECHNOLOGYAPPLIEDTOTHISVEHICLECOMPONENTANDPERCENTAGEOFEACHENERGYLOSSFIGURE1SHOWSENERGYLOSSESOFTHEPREVIOUSMODELEVTHELOSSESINCLUDEACCELERATIONRESISTANCE,DRIVINGRESISTANCE,LOSSESFROMSYSTEMCOMPONENTSINCLUDINGTHEMOTORANDTHECHARGER,ANDLOSSESOFBATTERYCHARGINGANDDISCHARGINGINTHISDEVELOPMENT,IMPROVEMENTSHAVEBEENMADEWITHTHEAIMOFREDUCINGOVERALLLOSSESBY40THEFOLLOWINGSECTIONSEXPLAININDETAILTHEIMPROVEMENTSMADETOREDUCELOSSOFEACHTYPEFIGURE1LOSSESINPREVIOUSMODELEVDEVELOPMENTOFANEWPOWERTRAINFORSUBCOMPACTELECTRICVEHICLES2013011478PUBLISHED04/08/2013AKIRAKABASAWA,KENICHIROKIMURA,TAKESHITAGUCHIANDAKIHIROANEKAWAHONDARDCO,LTDCOPYRIGHT?2013SAEINTERNATIONALDOI104271/2013011478DOWNLOADEDFROMSAEINTERNATIONALBYNORTHCAROLINAATUNIVERSITY,THURSDAY,JUNE08,2017LIMITEDTHEDEVELOPEDMODELRAPIDLYANDACCURATELYCOORDINATESTHEBRAKINGTORQUEPRODUCEDBYBOTHTHEHYDRAULICBRAKESANDREGENERATIVEBRAKES,ALLOWINGMOREEFFICIENTUSEOFREGENERATIVEENERGYFIGURE5SHOWSASCHEMATICDIAGRAMDEPICTINGTHEOPERATIONOFTHEELECTRICALLYOPERATEDSERVOBRAKESYSTEMFIGURE5SCHEMATICDIAGRAMOFELECTRICSERVOBRAKESYSTEMFIGURE6EFFECTOFELECTRICBRAKESERVOSYSTEMINTHISSYSTEM,THEOPERATIONOFTHEPEDALANDTHEMECHANISMFORAPPLYINGTHEBRAKEAREINDEPENDENTWHENTHEDRIVERSTEPSONTHEPEDAL,ASTROKESENSORPRODUCESASIGNAL,THESERVOMOTORROTATESINRESPONSETOTHESIGNALANDDRIVESABALLSCREW,PRODUCINGTHESAMESTROKEASTHEDRIVERSPEDALMOVEMENTABRUSHLESSMOTORASTHESERVOMOTORANDABALLSCREWACHIEVEHIGHLYPRECISEFLUIDPRESSURECONTROLANDAFASTRESPONSETHROUGHTHISMECHANISM,THEBRAKEISABLETOREGENERATEMOREENERGYOVERACOURSEOFDRIVINGTHANTHEPREVIOUSMECHANISMS,FROMTHEINSTANTTHEDRIVERPRESSESTHEBRAKEPEDALRIGHTUPTOTHEINSTANTTHEVEHICLESTOPSTHISINCREASESREGENERATIVEENERGYBYAPPROXIMATELY8FIGURE6SHOWSTHEEFFECTOFTHISSYSTEMREDUCTIONOFDRIVINGRESISTANCEFORREDUCINGTHEDRIVINGRESISTANCE,THEAERODYNAMICPERFORMANCEWASIMPROVEDINCOMPARISONWITHTHEBASEMODELWITHANINTERNALCOMBUSTIONENGINE,ANEVREQUIRESMUCHLOWERCOOLINGPERFORMANCEOFITSPOWERTRAINTHEREFORE,REDUCTIONOFAIRRESISTANCEWASENABLEDBYREDUCINGTHEAIRINTAKEBY30FURTHERMORE,ABATTERYPACKFORMINGAFLATUNDERBODYREDUCEDANAERODYNAMICRESISTANCESINCEANEVNOLONGERREQUIRESANEXHAUSTPIPEFIGURE7SHOWSTHEPARTTHATHASBEENMODIFIEDFROMTHEBASEMODELWITHANINTERNALCOMBUSTIONENGINETHUSWEWEREABLETOIMPROVE15TOAIRRESISTANCECOEFFICIENTFIGURE7IMPROVEMENTINAERODYNAMICRESISTANCEREDUCTIONOFBATTERYLOSSTHOUGHTHEPREVIOUSMODELUSEDNICKELMETALHYDRIDEBATTERIES,THEDEVELOPEDMODELADOPTSTHELITHIUMIONBATTERIESBECAUSEOFTHEHIGHERENERGYDENSITYANDHIGHERCHARGE/DISCHARGEEFFICIENCYINSPITEOFTHEENERGYDENSITYANDTHEEFFICIENCY,BATTERYCAPACITYFADEHASTOBETAKENINTOACCOUNTWHENUSINGLITHIUMIONBATTERIESASAVEHICLEENERGYSOURCEIMPROVEMENTOFDURABILITYOFTHELITHIUMIONBATTERYISDESCRIBEDBELOWIMPROVEMENTOFBATTERYDURABILITYONEOFTHEFACTORSTHATALITHIUMIONBATTERYDEGRADESISTHEDEPOSITIONOFMETALLICLITHIUMONTHENEGATIVEELECTRODEPOTENTIALDIFFERENCEBETWEENAPOSITIVEELECTRODEANDACARBONNEGATIVEELECTRODEOFALITHIUMIONBATTERYISNEAR42V,ANDDOWNLOADEDFROMSAEINTERNATIONALBYNORTHCAROLINAATUNIVERSITY,THURSDAY,JUNE08,2017
        下載積分: 10 賞幣
        上傳時間:2024-03-13
        頁數(shù): 5
        19人已閱讀
        ( 4 星級)
      • 簡介:ULTRAWIDEBANDSAMPLINGDOWNCONVERTERWITHSAMPLINGPHASEDETECTORALEXANDERREISENZAHN,STUDENTMEMBER,IEEE,STEFANMATZINGER,THOMASBUCHEGGER,STUDENTMEMBER,IEEE,SEBASTIANHANTSCHER,CHRISTIANGDISKUS,SENIORMEMBER,IEEEAREISENZAHN,SMATZINGER,SHANTSCHER,CGDISKUSAREWITHTHEINSTITUTEFORMICROELECTRONICSATTHEJOHANNESKEPLERUNIVERSITY,ALTENBERGERSTRASSE69,LINZ,4040,AUSTRIA,EMAILALEXANDERREISENZAHNJKUATTBUCHEGGERISWITHTHELINZCENTEROFCOMPETENCEINMECHATRONICS,ALTENBERGERSTRASSE69,LINZ,4040,AUSTRIAABSTRACTULTRAWIDEBANDRADARISANEXCELLENTTOOLFORNONDESTRUCTIVEEXAMINATIONOFWALLSANDHIGHWAYSTRUCTURESTHEREFOREOFTENSTEEPEDGEDNARROWPULSESWITHRISE,FALLTIMESINTHERANGEOF100PSAREUSEDFORDIGITIZINGOFTHEREFLECTEDPULSESADOWNCONVERSIONHASTOBEACCOMPLISHEDANEWLOWCOSTSAMPLINGDOWNCONVERTERWITHASAMPLINGPHASEDETECTORFORUSEINULTRAWIDEBANDRADARAPPLICATIONSISPRESENTEDKEYWORDSULTRAWIDEBAND,SAMPLINGPHASEDETECTOR,SAMPLINGDOWNCONVERTER,SAMPLINGCIRCUITIINTRODUCTIONULTRAWIDEBANDUWBPULSESAREVERYATTRACTIVEFORRADARAPPLICATIONSADVANTAGESAREAHIGHERRANGEMEASUREMENTACCURACYANDRANGESOLUTIONDUETOTHESHORTPULSEDURATION,IMMUNITYTOPASSIVEINTERFERERSANDMANYOTHERSTHESPECTRUMSTARTSATVERYLOWFREQUENCIESANDEXTENDSTOVERYHIGHFREQUENCIESTHEFEDERALCOMMUNICATIONSCOMMISSIONFCCALLOCATESAFREQUENCYRANGEOF75GHZFROM31GHZUPTO106GHZFORUNLICENSEDUSEINCOMMUNICATIONORRADARAPPLICATIONSANDFROM2GHZTO106GHZFORTHROUGHWALLIMAGING1THEFORMOFTHEREFLECTEDPULSEYIELDSTHETARGETINFORMATIONTOENABLEANINTERPRETATIONOFTHESIGNALANANALOGTODIGITALCONVERSIONISNECESSARYTODAYADIRECTCONVERSIONOFPULSESINTHESUBNANOSECONDREGIONISIMPOSSIBLETHEREFOREASAMPLINGDOWNCONVERTERISNECESSARY,WHICHISUSEDFOREXAMPLEINSAMPLINGOSCILLOSCOPESANDRADARAPPLICATIONSTHEDISCUSSEDSAMPLINGDOWNCONVERTERSHOULDBEUSEFULFORLOWCOSTUWBRADARAPPLICATIONSLIKEDETECTINGHIDDENINCLUSIONSINWALLSTHEFUNCTIONPRINCIPLEOFASAMPLINGDOWNCONVERTERISEXPLAINEDINTHEFOLLOWINGPULSESWITHAPULSEREPETITIONTIMETPRARESENTBYATRANSMITTERFIG1SHOWSTHEREFLECTEDPULSESTHESEPULSESHAVEADURATIONTPLOFSOMEHUNDREDPICOSECONDSTHESAMPLERHASTOBETURNEDONAFTERALITTLELONGERTIMETHANTHEPULSEREPETITIONTIMETPRTHISCANBEACCOMPLISHEDFOREXAMPLEWITHASLIGHTLYHIGHERFREQUENCYFPR30MHZ,FSAMPLE30000001MHZORTHESAMPLINGCLOCKISPHASESHIFTEDWITHADIRECTDIGITALSYNTHESIZERDDSATEACHREFLECTEDPULSEASAMPLEISTAKEN,MARKEDBYTHEDOTSTHEACCUMULATEDSAMPLESFORMTHEDOWNCONVERTEDPULSESTIMEAMPLITUDETPRTPLTSAMPLEFIGURE1PRINCIPLEOFSAMPLINGDOWNCONVERSIONIISAMPLINGPHASEDETECTORINPREVIOUSPUBLICATIONS2,3THESAMPLINGDOWNCONVERTERHASBEENBUILTOFDISCRETEELEMENTSINTHEPRESENTEDCIRCUITRYTHESAMPLINGPHASEDETECTORSPDCONTAINSALLNECESSARYPARTSINONEPACKAGEUPTONOWSPDSHAVEBEENUSEDFORTHEPHASELOCKOFAVOLTAGECONTROLLEDOSCILLATORINTHEVHF,UHFANDMICROWAVERANGEINCOMMUNICATIONANDRADARAPPLICATION4,5ANDFORSYNCHRONIZATIONINPULSEBASEDUWBTRANSMISSIONSYSTEMS6ASPDCONSISTSOFASTEPRECOVERYDIODESRD,TWOCAPACITORSANDASERIESPAIROFSCHOTTKYDIODESASSHOWNINFIG2SPDLOINRFINIFOUTFIGURE2CIRCUITRYOFTHESAMPLINGPHASEDETECTORTHESRDISASPECIALDIODEWITHANEXTREMELYFASTRECOVERYTIMEINTHERANGEOFPICOSECONDSCHARGEISSTOREDDURINGTHEPOSITIVEHALFFROMASINUSOIDALSIGNALANDEXTRACTEDDURINGTHENEGATIVEHALFCYCLETOGENERATEACURRENTPULSEWITHARISETIMEEQUIVALENTTOTHERECOVERYTIMETHEREFORETHESRDGENERATESSTEPFUNCTIONSOFADIFFERENTIALSINUSOIDALLOINPUTSIGNALWHICHAREDIFFERENTIATEDTOPULSES078039433X/05/2000?2005IEEEAPMC2005PROCEEDINGSFIGURE5DOWNCONVERTEDUWBRADARPULSETHEPULSESHAPEAGREESMUCHBETTERWITHTHEORIGINALPULSEIFADDSISUSEDFORPHASESHIFTTHERESULTISDEPICTEDINFIG6THEPULSEREPETITIONFREQUENCYINTHISCASEWAS125MHZINONEPERIOD212SAMPLESARETAKENEVERYSAMPLEPOINTISAVERAGED640TIMESWHICHCAUSESAREDUCTIONOFTHEJITTERDUETOTHEPHASENOISEOFTHELOCALOSCILLATORTHISCIRCUITRYWASASSEMBLEDONROGERSDUROIDRT6010SUBSTRATEFIGURE6DOWNCONVERTEDUWBRADARPULSE,PHASESHIFTWITHDDSTHEMEASUREDCONVERSIONGAINWITHA3DBMSINUSOIDALRFINPUTSIGNALATDIFFERENTFREQUENCIESCANBESEENINFIG7THESCHOTTKYDIODESAREUNBIASEDINTHISCASE,REVERSEBIASINGWOULDINCREASETHEBANDWIDTHTHE3DBCUTOFFFREQUENCYISABOUT64GHZTHERESULTCONFIRMSTHATTHEASSUMPTIONSTHATHAVEBEENTAKENAGREEQUITEWELLWITHTHEREALITYTHEFLATCHARACTERISTICOFTHECONVERSIONGAINARISESFROMTHELARGERFINPUTBANDWIDTHOFTHEUSEDSPDTHEBREAKINSAT42GHZANDAT53GHZAREPROBABLYCAUSEDBYTHEUSEDSMACONNECTORSFIGURE7CONVERSIONGAINOFTHESAMPLINGDOWNCONVERTERVCONCLUSIONANEWLOWCOSTSAMPLINGDOWNCONVERTERFORULTRAWIDEBANDRADARAPPLICATIONSWITHLOWSAMPLINGRATESUSINGASAMPLINGPHASEDETECTORISPRESENTEDTHECIRCUITDISPLAYSACONVERSIONGAINOF8DBFORA64GHZRFBANDWIDTHWITHOUTBIASINGTHESCHOTTKYDIODESTHEIMPULSEGENERATORWASREALIZEDWITHANEWLOFEEDUSINGADIFFERENTIALOPERATIONALAMPLIFIER,WHICHISPOSSIBLEUPTOSOMEHUNDREDMEGASAMPLESPERSECONDTHELOSIGNALISTRANSFORMEDFROMSINGLEENDEDTOBALANCEDBEFOREGENERATINGTHESAMPLINGPULSESTHISTRANSFORMATIONINFRONTOFTHESRDMAKESABROADBANDHYBRIDJUNCTIONUNNECESSARYTHEUSEOFTHESPDFORASAMPLINGDOWNCONVERTERISNEWTHESPDCONTAINSALLNECESSARYPARTSFORPULSEGENERATIONANDSAMPLINGINONEPACKAGEANDTHEREFOREALLOWSACOMPACT,LOWCOSTANDSIMPLETOMANUFACTURECIRCUITACKNOWLEDGMENTTHISWORKWASCARRIEDOUTATTHEINSTITUTEFORMICROELECTRONICSIME,JOHANNESKEPLERUNIVERSITY,LINZWEWOULDLIKETOACKNOWLEDGEBERNHARDMAYHOFERFORHISHELPINMANUFACTURINGTHETESTHARDWAREREFERENCES1“FIRSTREPORTANDORDER,REVISIONOFPART15OFTHECOMMISSION’SRULESREGARDINGULTRAWIDEBANDTRANSMISSIONSYSTEMS,”FCC,WASHINGTON,DC,ETDOCKET98153,20022JSLEE,CNGUYEN,“ALOWCOSTUNIPLANARSAMPLINGDOWNCONVERTERWITHINTERNALLOCALOSCILLATOR,PULSEGENERATORANDIFAMPLIFIER,”IEEETRANSONMICROWAVETHEORYANDTECHNIQUES,VOL49,PP390392,FEB20013JHAN,CNGUYEN,“INTEGRATEDBALANCEDSAMPLINGCIRCUITFORULTRAWIDEBANDCOMMUNICATIONANDRADARSYSTEMS,”IEEEMICROWAVEANDWIRELESSCOMPONENTLETTERS,VOL10,PP460462OCT20044“THEORYANDAPPLICATIONOFSAMPLINGPHASEDETECTORS,”APPLICATIONNOTEAPN5001,SKYWORKSSOLUTIONS,INCAVAILABLEHTTP//WWWSKYWORKSINCCOM5SAMPLINGPHASEDETECTORAPPLICATIONNOTE,AEROFLEX/METELICS,INCAVAILABLE
        下載積分: 10 賞幣
        上傳時間:2024-03-13
        頁數(shù): 4
        8人已閱讀
        ( 4 星級)
      • 簡介:SEEDISCUSSIONS,STATS,ANDAUTHORPROFILESFORTHISPUBLICATIONATHTTPS//WWWRESEARCHGATENET/PUBLICATION/26244358COMPETITIVEINHIBITIONOFHUMANPOLYASPECIFICRIBONUCLEASEPARNBYSYNTHETICFLUOROPYRANOSYLNUCLEOSIDESARTICLEINBIOCHEMISTRYJULY2009IMPACTFACTOR302DOI101021/BI900236KSOURCEPUBMEDCITATIONS21READS739AUTHORS,INCLUDINGPANAGIOTISMARAGOZIDISUNIVERSITYOFTHESSALY9PUBLICATIONS67CITATIONSSEEPROFILESTELLAMANTAUNIVERSITYOFTHESSALY50PUBLICATIONS388CITATIONSSEEPROFILEDIMITRIOSANASTASAKISUNIVERSITYOFPATRAS4PUBLICATIONS42CITATIONSSEEPROFILEDIMITRIKOMIOTISUNIVERSITYOFTHESSALY89PUBLICATIONS808CITATIONSSEEPROFILEAVAILABLEFROMDIMITRIOSVLACHAKISRETRIEVEDON29JANUARY2016ARTICLEBIOCHEMISTRY,VOL48,NO26,20096045NUCLEOTIDESANDNUCLEOSIDES,ANDTHEACTIVEMETABOLITESTARGETONEORMOREENZYMES,SUCHASDNAANDRNAPOLYMERASESRIBONUCLEASEACTIVITIESCOULDALSOREPRESENTPOTENTIALMOLECULARTARGETSFORINHIBITIONBYNUCLEOSIDEANALOGUESSUCHISTHECASEOFTHERNASEHDOMAINOFHIVRNADEPENDENTDNAPOLYMERASE2628DURINGRECENTYEARS,NUCLEOSIDEANALOGUESWITHASIXMEMBEREDCARBOHYDRATEMOIETY,SUCHASKETONUCLEOSIDES,HAVEBEENEVALUATEDFORTHEIRANTICANCERANDANTIVIRALPOTENTIAL2932FURTHERMORE,THEADDITIONOFAFLUORINEATOMONTHESUGARRINGANDTHEADDITIONOFABENZOYLGROUPONTHEBASEIMPROVESTHEBIOLOGICALACTIVITYOFTHEANALOGUEREF31ANDREFERENCESTHEREINHOWEVER,NOMOLECULARTARGETOFTHESECOMPOUNDSORTHEIRSYNTHETICINTERMEDIATESHASBEENIDENTIFIEDSOFARTHEABOVEMENTIONEDWORK,PROMPTEDUSTOSTUDYHUMANPARNASAPOTENTIALMOLECULARTARGETFORINHIBITIONBYSUCHNUCLEOSIDEANALOGUESWEFOCUSEDONTHISENZYMEGIVENTHATITSACTIVITYISREDUCEDBYNATURALNUCLEOTIDES,ITSSTRUCTUREISKNOWNTOASIGNIFICANTEXTENT,ANDITEXHIBITSTHEMAJORDEADENYLATIONACTIVITYINMAMMALSWEDEMONSTRATETHATPARNCANBEEFFICIENTLYINHIBITEDBYSEVERALNUCLEOSIDEANALOGUESBEARINGASIXMEMBEREDFLUOROMODIFIEDSUGARMOIETYWITHORWITHOUTTHEBENZOYLGROUPONTHEBASEADENINEORCYTOSINEWEFINDTHATTHESEANALOGUESBEHAVEASCOMPETITIVEINHIBITORSOFPARNANDMOREIMPORTANTLY,INCREASEDMAGNESIUMIIIONCONCENTRATIONSCOULDNOTRESTORETHEENZYME’SACTIVITYTOSUPPORTOURBIOCHEMICALDATA,WEPERFORMEDMOLECULARDOCKINGEXPERIMENTSFOLLOWEDBYMOLECULARDYNAMICSMDSIMULATIONS,ANDWEPREDICTEDTHEDOCKINGCONFORMATIONOFTHENUCLEOSIDESINTOTHEACTIVESITEBOTHTHEBIOCHEMICALANDTHEINSILICO3DMODELANALYSESREVEALEDACRUCIALROLEOFTHETHREEHYDROXYLGROUPSOFTHESUGARMOIETYFOREFFICIENTINHIBITORYEFFECTOURDATASUGGESTTHATTHEANALOGUESUSEDINTHEPRESENTSTUDYCOULDSERVEASLEADCOMPOUNDSFORTHEDEVELOPMENTOFNOVELINHIBITORSOFPARNANDPOSSIBLYOTHERESSENTIALDEADENYLASESWITHPOTENTIALUSEFORNOVELTHERAPEUTICAPPROACHESMATERIALSANDMETHODSMATERIALSALLCHEMICALSINCLUDINGPURINERIBONUCLEOTIDESANDDEOXYNUCLEOTIDES,METHYLENEBLUE,ANDPOLYADENYLICACIDPOTASSIUMSALTAVERAGESIZE300ADENOSINES,A300WEREFROMSIGMAALDRICHSYNTHESISOFNUCLEOSIDESANALOGUESTHEFLUOROPYRANOSYLNUCLEOSIDESWERESYNTHESIZEDASPREVIOUSLYDESCRIBED31BRIEFLY,CONDENSATIONOF1,2,4,6TETRAOACETYL3DEOXY3FLUOROGLUCOPYRANOSEWITHCYTOSINE,SILYATEDN4BENZOYLCYTOSINE,ORN6BENZOYLADENINERESULTEDINTHEPRODUCTIONOF120,40,60TRIOACETYL30DEOXY30FLUOROΒDGLUCOPYRANOSYLN4BENZOYLCYTOSINEA5OR920,40,60TRIOACETYL30DEOXY30FLUOROΒDGLUCOPYRANOSYLN6BENZOYLADENINEA1,RESPECTIVELY,INTHEPRESENCEOFTRIMETHYLSILYLTRIFLUOROMETHANESULFONATEANDTINCHLORIDEDEPROTECTIONOFA5ANDA1WITHNAOHETHANOLPYRIDINEYIELDED130,40DIDEOXY30FLUOROΒDGLUCOPYRANOSYLCYTOSINEC6,130,40DIDEOXY30FLUOROΒDGLUCOPYRANOSYLN4BENZOYLCYTOSINEA6,OR930,40DIDEOXY30FLUOROΒDGLUCOPYRANOSYLN6BENZOYLADENINEA2,RESPECTIVELYTREATMENTOFA2WITH2,2DIMETHOXYPROPANEINDRYN,NDIMETHYLFORMAMIDE,FOLLOWEDBYACETYLATIONOFTHEFREEHYDROXYLGROUPINTHE20POSITIONOFTHESUGARMOIETYWITHACETICANHYDRIDE/PYRIDINE,REMOVALOFTHEISOPROPYLIDENEGROUP,AND,FINALLY,SELECTIVEPROTECTIONOFTHEPRIMARY60HYDROXYLGROUPWITHATRITYLGROUPYIELDEDCOMPOUNDA4OXIDATIONOFTHEFLUOROACETYLATEDPRECURSORA4WITHPYRIDINIUMDICHROMATE/ACETICANHYDRIDEAFFORDED930DEOXY30FLUORO60OTRITYLΒDGLYCEROHEX20ENOPYRANOSYL40ULOSEN6BENZOYLADENINEA3EXPRESSIONANDPURIFICATIONOFRECOMBINANTPARNTHEPLASMIDENCODINGFULLSIZE74KDAHUMANPARNKINDLYPROVIDEDBYPROFAVIRTANEN,UPPSALAUNIVERSITY,SWEDENFOREXPRESSIONOFNTERMINALHIS6TAGGEDPOLYPEPTIDEWASTRANSFORMEDINTOBL21DE3CELLSTOEXPRESSTHERECOMBINANTPROTEINASDESCRIBEDPREVIOUSLY33WITHSOMEMODIFICATIONSBRIEFLY,COLONIESWEREGROWNOVERNIGHTAT37?CINTHEPRESENCEOFKANAMYCIN50ΜG/MLTHECULTURESWERETHENDILUTED1100INTHESAMEMEDIUMANDGROWNAT37?CINDUCEDBYISOPROPYL1THIOΒDGALACTOPYRANOSIDEIPTGATAFINALCONCENTRATIONOF01MMCULTURESFORPARNEXPRESSIONWEREALLOWEDTOGROWFOR3HAT37?CCELLSWEREHARVESTEDBYCENTRIFUGATIONFOR20MINAT4?C,ANDPELLETSWEREFROZENAT70?CTHEEXPRESSEDHISTAGGEDSOLUBLEPROTEINSWEREPURIFIEDFOLLOWINGPREVIOUSLYDESCRIBEDPROTOCOLS33PARNACTIVITYASSAYANDKINETICANALYSISTHEENZYMATICACTIVITYWASDETERMINEDBYTHEMETHYLENEBLUEASSAYASDESCRIBEDBEFORE34DEADENYLATIONRATESASAFUNCTIONOFTIMEWEREDETERMINEDWITHTIMECOURSEASSAYSSUPPORTINGINFORMATION,FIGURES1METHYLENEBLUEBUFFERWASPREPAREDBYDISSOLVING12MGOFMETHYLENEBLUEINTO100MLOFMOPSBUFFER01MMOPSKOH,PH75,AND2MMEDTATHESTANDARDREACTIONBUFFERCONTAINED20MMHEPESKOHPH70,15MMMGCL2,100MMKCL,01UOFRNASIN,02MMEDTA,025MMDTT,10V/VGLYCEROL,AND007506MMOFPOLYAALLRIBONUCLEOTIDESWEREDISSOLVEDINREACTIONBUFFERPRIORTOUSETHEREACTIONSWEREPERFORMEDUSING001002MMRECOMBINANTPARNFORKINETICANALYSIS,THESUBSTRATECONCENTRATIONPOLYAVARIEDFROM0075TO06MM19THEFINALREACTIONVOLUMEWAS100ΜL,ANDTHEREACTIONWASPERFORMEDAT30?CFOR510MINTHEREACTIONWASTERMINATEDBYMIXINGTHEREACTIONSOLUTIONWITH900ΜLOFMETHYLENEBLUEBUFFER,ANDTHEMIXEDSOLUTIONWASINCUBATEDAT30?CFORANOTHER15MININTHEDARKINAWATERBATHTHEABSORBANCEAT662NMOF1MLOFSAMPLEWASMEASUREDONASPECTRONICGENESYS20SPECTROPHOTOMETERCOORDINATEPREPARATIONTHECOORDINATESOFPARNWEREOBTAINEDFROMTHEKNOWNPARNCRYSTALSTRUCTUREASDEPOSITEDWITHTHERCSBPROTEINDATABANKRCSBCODE2A1RONEOFTHETWOIDENTICALACTIVESITESOFTHEDIMERICFORMWASUSEDFORTHEDOCKINGCALCULATIONSALLCRYSTALLOGRAPHICWATERMOLECULESWEREREMOVEDFROMTHECOORDINATEFILEPRIORTODOCKINGHYDROGENATOMSANDPARTIALCHARGESWEREADDEDTOTHEENZYMEBYTHEMOLECULAROPERATINGENVIRONMENTMOEPROGRAM35USINGTHEAMBER94FORCEFIELDMOEUSEDTHEPEOEMETHODTOASSIGNPARTIALCHARGESFORALLPOTENTIALINHIBITORCOMPOUNDSAFTERALLNONHYDROGENATOMSWEREFIXED,THEPARNMOLECULEWASENERGETICALLYMINIMIZEDBYACOMBINATIONOFTHESTEEPESTDESCENT,CONJUGATEGRADIENT,ANDTRUNCATEDNEWTONMINIMIZATIONMETHODSWITHINMOEENERGYMINIMIZATIONSWEREALSOPERFORMEDTORELAXTHESUBSTRATESPRIORTODOCKINGMOLECULARDOCKINGTHEMOESUITEWASUSEDTOPERFORMDOCKINGEXPERIMENTSANDCALCULATIONSOFSOLVATIONANDRELATIVEBINDINGFREEENERGIESTHEDOCKMODULEOFMOEUTILIZESAMONTECARLOSIMULATEDANNEALINGSAMETHODINDOCKINGCALCULATIONSADOCKINGBOXOF60?40?40POINTSWITHAGRIDSPACINGOF0375A?WASPLACEDAROUNDTHEACTIVESITEOFTHEPROTEINFORTHISPURPOSETHEITERATIONLIMITWASSETTO20000,THENUMBEROFCYCLESWASSETTO20,ANDTHENUMBEROFRUNSWASSETTO10MOLECULARDYNAMICSSIMULATIONSMOLECULARDYNAMICSMDSIMULATIONSWEREPERFORMEDUSINGMOEANDITSBUILTINMDMODULEUSINGANNVTENSEMBLEN,NUMBEROFATOMSV,VOLUMET,TEMPERATURETHECOMPLEXESOFTHEENZYMEWITHTHEDOWNLOADEDBYCARDIFFUNIVONJULY9,2009PUBLISHEDONMAY27,2009ONHTTP//PUBSACSORG|DOI101021/BI900236K
        下載積分: 10 賞幣
        上傳時間:2024-03-13
        頁數(shù): 9
        2人已閱讀
        ( 4 星級)
      • 簡介:THEMEDSECTIONVECTORDESIGNANDDRUGDELIVERYREVIEWTWENTYYEARSOFCELLPENETRATINGPEPTIDESFROMMOLECULARMECHANISMSTOTHERAPEUTICSFREDERICHEITZ,MAYCATHERINEMORRISANDGILLESDIVITACENTREDERECHERCHESDEBIOCHIMIEMACROMOLéCULAIRE,UMR5237,CNRS,UM1,UM2,CRBMDEPARTMENTOFMOLECULARBIOPHYSICSANDTHERAPEUTICS,1919ROUTEDEMENDE,MONTPELLIER,FRANCETHERECENTDISCOVERYOFNEWPOTENTTHERAPEUTICMOLECULESTHATDONOTREACHTHECLINICDUETOPOORDELIVERYANDLOWBIOAVAILABILITYHAVEMADEOFDELIVERYAKEYSTONEINTHERAPEUTICDEVELOPMENTSEVERALTECHNOLOGIESHAVEBEENDESIGNEDTOIMPROVECELLULARUPTAKEOFTHERAPEUTICMOLECULES,INCLUDINGCELLPENETRATINGPEPTIDESCPPSCPPSWEREFIRSTDISCOVEREDBASEDONTHEPOTENCYOFSEVERALPROTEINSTOENTERCELLSNUMEROUSCPPSHAVEBEENDESCRIBEDSOFAR,WHICHCANBEGROUPEDINTOTWOMAJORCLASSES,THEFIRSTREQUIRINGCHEMICALLINKAGEWITHTHEDRUGFORCELLULARINTERNALIZATIONANDTHESECONDINVOLVINGFORMATIONOFSTABLE,NONCOVALENTCOMPLEXESWITHDRUGSNOWADAYS,CPPSCONSTITUTEVERYPROMISINGTOOLSFORNONINVASIVECELLULARIMPORTOFCARGOANDHAVEBEENSUCCESSFULLYAPPLIEDFORINVITROANDINVIVODELIVERYOFTHERAPEUTICMOLECULESVARYINGFROMSMALLCHEMICALMOLECULE,NUCLEICACIDS,PROTEINS,PEPTIDES,LIPOSOMESANDPARTICLESTHISREVIEWWILLFOCUSONTHESTRUCTURE/FUNCTIONANDCELLULARUPTAKEMECHANISMOFCPPSINTHEGENERALCONTEXTOFDRUGDELIVERYWEWILLALSOHIGHLIGHTTHEAPPLICATIONOFPEPTIDECARRIERSFORTHEDELIVERYOFTHERAPEUTICMOLECULESANDPROVIDEANUPDATEOFTHEIRCLINICALEVALUATIONBRITISHJOURNALOFPHARMACOLOGY2009157,195–206DOI101111/J14765381200800057XPUBLISHEDONLINE20MARCH2009THISARTICLEISPARTOFATHEMEDSECTIONONVECTORDESIGNANDDRUGDELIVERYFORALISTOFALLARTICLESINTHISSECTIONSEETHEENDOFTHISPAPER,ORVISITHTTP//WWW3INTERSCIENCEWILEYCOM/JOURNAL/121548564/ISSUEYEARYEAR2009KEYWORDSCELLPENETRATINGPEPTIDENONCOVALENTDELIVERYSYSTEMSIRNANANOPARTICLEDRUGDELIVERYMOLECULARMECHANISMSTHERAPEUTICSABBREVIATIONSCPP,CELLPENETRATINGPEPTIDEGAG,GLUCOSAMINOGLYCANNLS,NUCLEARLOCALIZATIONSEQUENCEPMO,PHOSPHORODIAMIDATEMORPHOLINOOLIGOMERPNA,PEPTIDENUCLEICACIDPTD,PROTEINTRANSDUCTIONDOMAINSINTRODUCTIONCHALLENGESINDRUGDELIVERYOVERTHEPAST10YEARS,INORDERTOCIRCUMVENTLIMITATIONSOFSMALLMOLECULEANDGENEBASEDTHERAPIES,WEHAVEWITNESSEDADRAMATICACCELERATIONINTHEPRODUCTIONOFNEWLARGETHERAPEUTICMOLECULES,WHICHDONOTFOLLOWLIPINSKI’SRULES,SUCHASPROTEINS,PEPTIDESANDNUCLEICACIDTHERAPEUTICSHOWEVER,THEIRDEVELOPMENTISRESTRICTEDBYVERYSPECIFICISSUESINCLUDINGPOORSTABILITYINVIVO,LACKOFCELLULARUPTAKEANDINSUFFICIENTCAPABILITYTOREACHTARGETSTHISISASSOCIATEDWITHTHECOMPLETELOSSOFPHARMACEUTICALPOTENCYORATLEASTWITHTHEREQUIREMENTFORHIGHDOSESANDRISKOFMAJORSIDEEFFECTSTHEREFORE,DELIVERYCONSTITUTESAMAJORPIECEOFTHETHERAPEUTICPUZZLE,ANDTHEREISAREALDEMANDFORNEWANDMOREEFFICIENTDRUGDELIVERYSYSTEMSMAJORRULESHAVETOBESATISFIED,INPARTICULARIDELIVERYEFFICIENCYINDIFFERENTANDCHALLENGINGCELLLINESIIRAPIDENDOSOMALRELEASEIIIABILITYTOREACHTHETARGETIVACTIVITYATLOWDOSESVLACKOFTOXICITYANDVIFACILITYOFTHERAPEUTICAPPLICATIONSUBSTANTIALPROGRESSHASBEENMADEINTHEDESIGNOFNEWTECHNOLOGIESTOIMPROVECELLULARUPTAKEOFTHERAPEUTICCOMPOUNDSOPALINSKAANDGEWIRTZ,2002J?RVERANDLANGEL,2004GLOVERETAL,2005TORCHILIN,2005DEFOUGEROLLESETAL,2007KONGANDMOONEY,2007ANUMBEROFNONVIRALSTRATEGIESHAVEBEENPROPOSEDINCLUDINGLIPID,POLYCATIONIC,NANOPARTICLEANDPEPTIDEBASEDFORMULATIONSASREPORTEDINTHISSPECIALISSUEMORRISETAL,2000OGRISANDWAGNER,2002J?RVERANDLANGEL,2004TORCHILIN,2005,BUTONLYASUBSETOFTHESETECHNOLOGIESAREEFFICIENTLYAPPLIEDINVIVOATEITHERPRECLINICALORCLINICALLEVELSPROTEINTRANSDUCTIONDOMAINSPTDSORCELLPENETRATINGPEPTIDESCPPSCORRESPONDTOSHORT30RESIDUESYNTHETICPEPTIDESANDAREPARTOFTHEMOSTPROMISINGSTRATEGYTOOVERCOMEBOTHEXTRACELLULARANDINTRACELLULARLIMITATIONSOFVARIOUSBIOMOLECULESOFINCLUDINGPLASMIDDNA,CORRESPONDENCEGILLESDIVITA,CENTREDERECHERCHESDEBIOCHIMIEMACROMOLéCULAIRE,UMR5237,CNRS,UM1,UM2,CRBMDEPARTMENTOFMOLECULARBIOPHYSICSANDTHERAPEUTICS,1919ROUTEDEMENDE,34293MONTPELLIER,FRANCEEMAILGILLESDIVITACRBMCNRSFRRECEIVED14JULY2008REVISED7OCTOBER2008ACCEPTED20OCTOBER2008BRITISHJOURNALOFPHARMACOLOGY2009,157,195–206?2009THEAUTHORSJOURNALCOMPILATION?2009THEBRITISHPHARMACOLOGICALSOCIETYALLRIGHTSRESERVED00071188/09WWWBRJPHARMACOLORGCOVALENTSTRATEGYCELLPENETRATINGPEPTIDEBASEDTECHNOLOGIESDESCRIBEDSOFARMAINLYINVOLVETHEFORMATIONOFACOVALENTCONJUGATEBETWEENTHECARGOANDTHECARRIERPEPTIDE,WHICHISACHIEVEDBYCHEMICALCROSSLINKINGORBYCLONINGFOLLOWEDBYEXPRESSIONOFACPPFUSIONPROTEINNAGAHARAETAL,1998GAIT,2003MOULTONANDMOULTON,2004ZATSEPINETAL,2005MOSTOFTHEWORKHASBEENREPORTEDFORPEPTIDESDERIVEDFROMTATFAWELLETAL,1994VIVESETAL,1997FRANKELANDPABO,1988,PENETRATINDEROSSIETAL,1994,POLYARGININEPEPTIDEARG8SEQUENCEWENDERETAL,2000FUTAKIETAL,2001ANDTRANSPORTAN,POOGAETAL,1998OTHERPROTEINDERIVEDPEPTIDESSUCHASVP22PROTEINFROMHERPESSIMPLEXVIRUSELLIOTTANDO’HARE,1997,PVECELMQUISTETAL,2001,CALCITONINDERIVEDPEPTIDESSCHMIDTETAL,1998KRAUSSETAL,2004,ANTIMICROBIALPEPTIDESBUFORINIANDSYNBPARKETAL,1998PARKETAL,2000,ASWELLASPOLYPROLINESWEETARROWPEPTIDEPUJALSETAL,2006HAVEALSOBEENSUCCESSFULLYUSEDTOIMPROVETHEDELIVERYOFCOVALENTLYLINKEDCARGOSJOLIOTANDPROCHIANTZ,2004ELANDALOUSSIETAL,2005MURRIELANDDOWDY,2006MORERECENTLY,NEWGENERATIONSOFCPPS,COMBININGDIFFERENTTRANSDUCTIONMOTIFSABESETAL,2007ORTRANSDUCTIONDOMAINSINTANDEMWITHPROTEINOROLIGONUCLEOTIDEBINDINGDOMAINSMEADEANDDOWDY,2007HAVEBEENPROPOSEDDIFFERENTCHEMISTRIESHAVEBEENPROPOSEDFORSTABLEORCLEAVABLECONJUGATIONINVOLVINGMAINLYDISULFIDEORTHIOESTERSLINKAGESACCORDINGTOTHESTABILITYANDEFFICIENCYOFTHECARGO,SEVERALPARAMETERSNEEDTOBECONSIDEREDINCLUDINGTHETYPEOFLINKAGECHEMISTRY,THENATUREOFTHESPACERGAIT,2003ZATSEPINETAL,2005COVALENTSTRATEGIESHAVEBEENMAINLYREPORTEDFORTHEDELIVERYOFDNAMIMICMOLECULESORSTERICBLOCKOLIGONUCLEOTIDES,INCLUDINGPNAKOPPELHUSETAL,2002FABANIETAL,2008,PHOSPHORODIAMIDATEMORPHOLINOOLIGOMERPMOABESETAL,2006LEBLEUETAL,2008MOULTONANDMOULTON,2008,PEPTIDEANDPROTEINSNYDERANDDOWDY,2005CONJUGATIONMETHODSOFFERSEVERALADVANTAGESFORINVIVOAPPLICATIONSINCLUDINGRATIONALIZATION,REPRODUCIBILITYOFTHEPROCEDURE,TOGETHERWITHTHECONTROLOFTHESTOECHIOMETRYOFTHECPPCARGOHOWEVER,THECOVALENTCPPTECHNOLOGYISLIMITEDFROMACHEMICALPOINTOFVIEWANDRISKSALTERINGTHEBIOLOGICALACTIVITYOFTHECARGOTHISISPARTICULARLYTRUE,INTHECASEOFCHARGEDOLIGONUCLEOTIDEORSIRNA,FORWHICHCPPCOUPLINGHASLEDTORESTRICTEDBIOLOGICALACTIVITIESJULIANOETAL,2008,NONCOVALENTSTRATEGIESTHEREBYAPPEARINGMOREAPPROPRIATENONCOVALENTSTRATEGYTHISSTRATEGYISMAINLYBASEDONSHORTAMPHIPATHICPEPTIDECARRIERSCONSISTINGOFTWODOMAINSAHYDROPHILICPOLARDOMAINANDAHYDROPHOBICNONPOLARDOMAINTABLE1THEAMPHIPATHICCHARACTERMAYARISEFROMEITHERTHEPRIMARYSTRUCTUREORTHESECONDARYSTRUCTUREPRIMARYAMPHIPATHICPEPTIDESCANBEDEFINEDASTHESEQUENTIALASSEMBLYOFADOMAINOFHYDROPHOBICRESIDUESWITHADOMAINOFHYDROPHILICRESIDUESSECONDARYAMPHIPATHICPEPTIDESAREGENERATEDBYTHECONFORMATIONALSTATETHATALLOWSPOSITIONINGOFHYDROPHOBICANDHYDROPHILICRESIDUESONOPPOSITESIDESOFTHEMOLECULEDESHAYESETAL,2005SEVERALCPPSHAVEBEENREPORTEDTOFORMNONCOVALENTCOMPLEXESWITHBIOMOLECULESANDTOIMPROVETHEIRDELIVERYINTOMAMMALIANCELLSMORRISETAL,2008NONCOVALENTAPPROACHWASORIGINALLYDEVELOPEDFORGENEDELIVERYSEVERALPEPTIDESABLETOCONDENSEDNAASSOCIATEDWITHPEPTIDESTHATFAVOURENDOSOMALESCAPEINCLUDINGFUSIONPEPTIDEOFHA2SUBUNITOFINFLUENZAHEMAGLUTININHAVEBEENDESCRIBEDLEARANDDEGRADO,1987PARENTEETAL,1990SYNTHETICPEPTIDESANALOGSGALA,KALA,JTS1GOTTSCHALKETAL,1996WYMANETAL,1997,PPTG1RITTNERETAL,2002,MPGMORRISETAL,1999ANDHISTIDINERICHPEPTIDESMIDOUXETAL,1998KICHLERETAL,2003WEREALSOREPORTEDASPOTENTGENEDELIVERYSYSTEMSIN2001,WEDEMONSTRATEDTHATTHEAMPHIPATHICPEPTIDEPEP1COULDBESUCCESSFULLYAPPLIEDTOTHEDELIVERYOFSMALLPEPTIDESANDPROTEINSINANONCOVALENTAPPROACHMORRISETAL,2001IN2003,ANONCOVALENTSTRATEGYBASEDONMPGWASSHOWNTOEFFICIENTLYDELIVERSIRNAINTOCULTUREDCELLLINESSIMEONIETAL,2003PEP1ANDMPGAREPRIMARYAMPHIPATHICPEPTIDESCONTAININGAHYDROPHILICLYSINERICHDOMAINDERIVEDFROMTHENUCLEARLOCALIZATIONSEQUENCENLSOFSV40LARGETANTIGENKKKRKV,ANDAVARIABLENTERMINALHYDROPHOBICMOIETYDERIVEDFORMTHEFUSIONSEQUENCEOFTHEHIVPROTEINGP41GALFLGFLGAAGSTMGAFORMPG,ANDFROMATRYPTOPHANRICHCLUSTERKETWWETWWTEWFORPEP1,SEPARATEDBYALINKERDOMAIN,WHICHIMPROVESTHEFLEXIBILITYANDTHEINTEGRITYOFBOTHTHEHYDROPHOBICANDHYDROPHILICDOMAINSMORRISETAL,1997MORRISETAL,1999SIMEONIETAL,2003MPGANDPEP1FORMSTABLECOMPLEXESWITHTHEIRRESPECTIVECARGOOLIGONUCLEOTIDEORPROTEIN/PEPTIDETHROUGHNONCOVALENTELECTROSTATICANDHYDROPHOBICINTERACTIONSMORRISETAL,199719992001SIMEONIETAL,2003GROSETAL,2006MUNOZMORRISETAL,2007NONCOVALENTSTRATEGIESFORPROTEINANDOLIGONUCLEOTIDEDELIVERYHAVEBEENRECENTLYBEENEXTENDEDTOOTHERCPPS,INCLUDINGTATMEADEANDDOWDY,2007,POLYARGININEKIMETAL,2006KUMARETAL,2007ANDTRANSPORTANDERIVEDPEPTIDESPOOGAETAL,2001LUNDBERGETAL,2007CELLULARUPTAKEMECHANISMOFCELLPENETRATINGPEPTIDESTHECELLULARUPTAKEMECHANISMOFCPPSISANESSENTIALPIECEOFTHEPUZZLEFORTHEDEVELOPMENTANDOPTIMIZATIONOFAPPROPRIATESTRATEGIESFORINVIVOTHERAPEUTICAPPLICATIONSALTHOUGHCELLULARINTERNALIZATIONOFCPPSWASREPORTEDINAWIDEVARIETYOFCELLTYPES,THEIRMECHANISMOFINTERNALIZATIONREMAINED‘MYSTERIOUS’FORALONGTIME,ASBEINGINDEPENDENTOFENDOCYTOSIS,OFENERGYANDOFSPECIFICRECEPTORINTHELAST5YEARS,THECPPFIELDHASSUFFEREDANDLEARNTFROMTECHNICALARTIFACTSASSUCH,IN2003,LEBLEUANDCOLLEAGUES,PROPOSEDAREVISEDCELLULARUPTAKEMECHANISMFORCPPS,ESSENTIALLYASSOCIATEDWITHTHEENDOSOMALPATHWAYRICHARDETAL,2003EVERSINCE,THEMECHANISMOFMANYCPPSHASREEXAMINEDANDREPORTEDTOBEMEDIATEDBYENDOCYTOSISLUNDBERGANDJOHANSSON,2001NAKASEETAL,2004WADIAETAL,2004FISCHERETAL,2005RICHARDETAL,2005MURRIELANDDOWDY,2006HOWEVER,FORMOSTCPPS,THECELLULARUPTAKEMECHANISMSTILLNEEDSTOBECONFIRMEDANDREMAINSCONTROVERSIAL,PARTLYDUETOTHEFACTTHATDIFFERENTMETHODS,WHICHARENOTCOMPARABLEFROMONELABPEPTIDEBASEDDRUGDELIVERYTECHNOLOGYFHEITZETAL197BRITISHJOURNALOFPHARMACOLOGY2009157195–206
        下載積分: 10 賞幣
        上傳時間:2024-03-13
        頁數(shù): 12
        14人已閱讀
        ( 4 星級)
      • 簡介:IEEETRANSACTIONSONEVOLUTIONARYCOMPUTATION,VOL1,NO1,APRIL199753ANTCOLONYSYSTEMACOOPERATIVELEARNINGAPPROACHTOTHETRAVELINGSALESMANPROBLEMMARCODORIGO,SENIORMEMBER,IEEE,ANDLUCAMARIAGAMBARDELLA,MEMBER,IEEEABSTRACTTHISPAPERINTRODUCESTHEANTCOLONYSYSTEMACS,ADISTRIBUTEDALGORITHMTHATISAPPLIEDTOTHETRAVELINGSALESMANPROBLEMTSPINTHEACS,ASETOFCOOPERATINGAGENTSCALLEDANTSCOOPERATETOFINDGOODSOLUTIONSTOTSP’SANTSCOOPERATEUSINGANINDIRECTFORMOFCOMMUNICATIONMEDIATEDBYAPHEROMONETHEYDEPOSITONTHEEDGESOFTHETSPGRAPHWHILEBUILDINGSOLUTIONSWESTUDYTHEACSBYRUNNINGEXPERIMENTSTOUNDERSTANDITSOPERATIONTHERESULTSSHOWTHATTHEACSOUTPERFORMSOTHERNATUREINSPIREDALGORITHMSSUCHASSIMULATEDANNEALINGANDEVOLUTIONARYCOMPUTATION,ANDWECONCLUDECOMPARINGACS3OPT,AVERSIONOFTHEACSAUGMENTEDWITHALOCALSEARCHPROCEDURE,TOSOMEOFTHEBESTPERFORMINGALGORITHMSFORSYMMETRICANDASYMMETRICTSP’SINDEXTERMSADAPTIVEBEHAVIOR,ANTCOLONY,EMERGENTBEHAVIOR,TRAVELINGSALESMANPROBLEMIINTRODUCTIONTHENATURALMETAPHORONWHICHANTALGORITHMSAREBASEDISTHATOFANTCOLONIESREALANTSARECAPABLEOFFINDINGTHESHORTESTPATHFROMAFOODSOURCETOTHEIRNEST3,22WITHOUTUSINGVISUALCUES24BYEXPLOITINGPHEROMONEINFORMATIONWHILEWALKING,ANTSDEPOSITPHEROMONEONTHEGROUNDANDFOLLOW,INPROBABILITY,PHEROMONEPREVIOUSLYDEPOSITEDBYOTHERANTSINFIG1,WESHOWAWAYANTSEXPLOITPHEROMONETOFINDASHORTESTPATHBETWEENTWOPOINTSCONSIDERFIG1AANTSARRIVEATADECISIONPOINTINWHICHTHEYHAVETODECIDEWHETHERTOTURNLEFTORRIGHTSINCETHEYHAVENOCLUEABOUTWHICHISTHEBESTCHOICE,THEYCHOOSERANDOMLYITCANBEEXPECTEDTHAT,ONAVERAGE,HALFOFTHEANTSDECIDETOTURNLEFTANDTHEOTHERHALFTOTURNRIGHTTHISHAPPENSBOTHTOANTSMOVINGFROMLEFTTORIGHTTHOSEWHOSENAMEBEGINSWITHANLANDTOTHOSEMOVINGFROMRIGHTTOLEFTNAMEBEGINSWITHANRFIG1BANDCSHOWSWHATHAPPENSINTHEIMMEDIATELYFOLLOWINGINSTANTS,SUPPOSINGTHATALLANTSWALKATAPPROXIMATELYTHESAMESPEEDTHENUMBEROFDASHEDLINESISROUGHLYPROPORTIONALTOTHEAMOUNTOFPHEROMONETHATTHEANTSHAVEDEPOSITEDONTHEGROUNDSINCETHELOWERPATHISSHORTERTHANTHEUPPERONE,MOREANTSWILLVISITITONAVERAGE,ANDTHEREFOREPHEROMONEACCUMULATESFASTERAFTERASHORTTRANSITORYPERIODTHEDIFFERENCEINTHEAMOUNTOFPHEROMONEONTHETWOPATHSISSUFFICIENTLYLARGESOASTOINFLUENCETHEDECISIONOFNEWANTSCOMINGINTOTHESYSTEMTHISISSHOWNBYMANUSCRIPTRECEIVEDOCTOBER7,1996REVISEDJANUARY18,1997ANDFEBRUARY3,1997THISWORKWASSUPPORTEDBYTHESWISSNATIONALSCIENCEFUNDCONTRACT214565395MDORIGOISWITHIRIDIA,UNIVERSITELIBREDEBRUXELLES,1050BRUXELLES,BELGIUMEMAILMDORIGOULBACBELMGAMBARDELLAISWITHIDSIA,6900LUGANO,SWITZERLANDPUBLISHERITEMIDENTIFIERS1089778X97033031FIG1DFROMNOWON,NEWANTSWILLPREFERINPROBABILITYTOCHOOSETHELOWERPATH,SINCEATTHEDECISIONPOINTTHEYPERCEIVEAGREATERAMOUNTOFPHEROMONEONTHELOWERPATHTHISINTURNINCREASES,WITHAPOSITIVEFEEDBACKEFFECT,THENUMBEROFANTSCHOOSINGTHELOWER,ANDSHORTER,PATHVERYSOONALLANTSWILLBEUSINGTHESHORTERPATHTHEABOVEBEHAVIOROFREALANTSHASINSPIREDANTSYSTEM,ANALGORITHMINWHICHASETOFARTIFICIALANTSCOOPERATETOTHESOLUTIONOFAPROBLEMBYEXCHANGINGINFORMATIONVIAPHEROMONEDEPOSITEDONGRAPHEDGESTHEANTSYSTEMHASBEENAPPLIEDTOCOMBINATORIALOPTIMIZATIONPROBLEMSSUCHASTHETRAVELINGSALESMANPROBLEMTSP7,8,10,12ANDTHEQUADRATICASSIGNMENTPROBLEM32,42THEANTCOLONYSYSTEMACS,THEALGORITHMPRESENTEDINTHISARTICLE,BUILDSONTHEPREVIOUSANTSYSTEMINTHEDIRECTIONOFIMPROVINGEFFICIENCYWHENAPPLIEDTOSYMMETRICANDASYMMETRICTSP’STHEMAINIDEAISTHATOFHAVINGASETOFAGENTS,CALLEDANTS,SEARCHINPARALLELFORGOODSOLUTIONSTOTHETSPANDCOOPERATETHROUGHPHEROMONEMEDIATEDINDIRECTANDGLOBALCOMMUNICATIONINFORMALLY,EACHANTCONSTRUCTSATSPSOLUTIONINANITERATIVEWAYITADDSNEWCITIESTOAPARTIALSOLUTIONBYEXPLOITINGBOTHINFORMATIONGAINEDFROMPASTEXPERIENCEANDAGREEDYHEURISTICMEMORYTAKESTHEFORMOFPHEROMONEDEPOSITEDBYANTSONTSPEDGES,WHILEHEURISTICINFORMATIONISSIMPLYGIVENBYTHEEDGE’SLENGTHTHEMAINNOVELIDEAINTRODUCEDBYANTALGORITHMS,WHICHWILLBEDISCUSSEDINTHEREMAINDEROFTHEPAPER,ISTHESYNERGISTICUSEOFCOOPERATIONAMONGMANYRELATIVELYSIMPLEAGENTSWHICHCOMMUNICATEBYDISTRIBUTEDMEMORYIMPLEMENTEDASPHEROMONEDEPOSITEDONEDGESOFAGRAPHTHISPAPERISORGANIZEDASFOLLOWSSECTIONIIPUTSTHEACSINCONTEXTBYDESCRIBINGANTSYSTEM,THEPROGENITOROFTHEACSSECTIONIIIINTRODUCESTHEACSSECTIONIVISDEDICATEDTOTHESTUDYOFSOMECHARACTERISTICSOFTHEACSWESTUDYHOWPHEROMONECHANGESATRUNTIME,ESTIMATETHEOPTIMALNUMBEROFANTSTOBEUSED,OBSERVETHEEFFECTSOFPHEROMONEMEDIATEDCOOPERATION,ANDEVALUATETHEROLETHATPHEROMONEANDTHEGREEDYHEURISTICHAVEINACSPERFORMANCESECTIONVPROVIDESANOVERVIEWOFRESULTSONASETOFSTANDARDTESTPROBLEMSANDCOMPARISONSOFTHEACSWITHWELLKNOWNGENERALPURPOSEALGORITHMSLIKEEVOLUTIONARYCOMPUTATIONANDSIMULATEDANNEALINGINSECTIONVIWEADDLOCALOPTIMIZATIONTOTHEACS,OBTAININGANEWALGORITHMCALLEDACS3OPTTHISALGORITHMISCOMPAREDFAVORABLYWITHTHEWINNEROFTHEFIRSTINTERNATIONALCONTESTONEVOLUTIONARYOPTIMIZATION5ONASYMMETRICTSPATSPPROBLEMSSEEFIG2,WHILEITYIELDSASLIGHTLYWORSEPERFORMANCEONTSPPROBLEMSSECTIONVIIIS1089–778X/971000?1997IEEEDORIGOANDGAMBARDELLAANTCOLONYSYSTEM55FIG3THEACSALGORITHMPROBABILITYWITHWHICHANTINCITYCHOOSESTOMOVETOTHECITYIFOTHERWISE1WHEREISTHEPHEROMONE,ISTHEINVERSEOFTHEDISTANCE,ISTHESETOFCITIESTHATREMAINTOBEVISITEDBYANTPOSITIONEDONCITYTOMAKETHESOLUTIONFEASIBLE,ANDISAPARAMETERWHICHDETERMINESTHERELATIVEIMPORTANCEOFPHEROMONEVERSUSDISTANCEIN1WEMULTIPLYTHEPHEROMONEONEDGEBYTHECORRESPONDINGHEURISTICVALUEINTHISWAYWEFAVORTHECHOICEOFEDGESWHICHARESHORTERANDWHICHHAVEAGREATERAMOUNTOFPHEROMONEINANTSYSTEM,THEGLOBALUPDATINGRULEISIMPLEMENTEDASFOLLOWSONCEALLANTSHAVEBUILTTHEIRTOURS,PHEROMONEISUPDATEDONALLEDGESACCORDINGTO2WHEREIFTOURDONEBYANTOTHERWISEISAPHEROMONEDECAYPARAMETER,ISTHELENGTHOFTHETOURPERFORMEDBYANT,ANDISTHENUMBEROFANTSPHEROMONEUPDATINGISINTENDEDTOALLOCATEAGREATERAMOUNTOFPHEROMONETOSHORTERTOURSINASENSE,THISISSIMILARTOAREINFORCEMENTLEARNINGSCHEME2,26INWHICHBETTERSOLUTIONSGETAHIGHERREINFORCEMENTASHAPPENS,FOREXAMPLE,INGENETICALGORITHMSUNDERPROPORTIONALSELECTIONTHEPHEROMONEUPDATINGFORMULAWASMEANTTOSIMULATETHECHANGEINTHEAMOUNTOFPHEROMONEDUETOBOTHTHEADDITIONOFNEWPHEROMONEDEPOSITEDBYANTSONTHEVISITEDEDGESANDTOPHEROMONEEVAPORATIONPHEROMONEPLACEDONTHEEDGESPLAYSTHEROLEOFADISTRIBUTEDLONGTERMMEMORYTHISMEMORYISNOTSTOREDLOCALLYWITHINTHEINDIVIDUALANTS,BUTISDISTRIBUTEDONTHEEDGESOFTHEGRAPHTHISALLOWSANINDIRECTFORMOFCOMMUNICATIONCALLEDSTIGMERGY9,23THEINTERESTEDREADERWILLFINDAFULLDESCRIPTIONOFANTSYSTEM,OFITSBIOLOGICALMOTIVATIONS,ANDCOMPUTATIONALRESULTSIN12ALTHOUGHANTSYSTEMWASUSEFULFORDISCOVERINGGOODOROPTIMALSOLUTIONSFORSMALLTSP’SUPTO30CITIES,THETIMEREQUIREDTOFINDSUCHRESULTSMADEITINFEASIBLEFORLARGERPROBLEMSWEDEVISEDTHREEMAINCHANGESTOIMPROVEITSPERFORMANCEWHICHLEDTOTHEDEFINITIONOFTHEACS,PRESENTEDINTHENEXTSECTIONIIIACSTHEACSDIFFERSFROMTHEPREVIOUSANTSYSTEMBECAUSEOFTHREEMAINASPECTSITHESTATETRANSITIONRULEPROVIDESADIRECTWAYTOBALANCEBETWEENEXPLORATIONOFNEWEDGESANDEXPLOITATIONOFAPRIORIANDACCUMULATEDKNOWLEDGEABOUTTHEPROBLEM,IITHEGLOBALUPDATINGRULEISAPPLIEDONLYTOEDGESWHICHBELONGTOTHEBESTANTTOUR,ANDIIIWHILEANTSCONSTRUCTASOLUTIONALOCALPHEROMONEUPDATINGRULELOCALUPDATINGRULE,FORSHORTISAPPLIEDINFORMALLY,THEACSWORKSASFOLLOWSANTSAREINITIALLYPOSITIONEDONCITIESCHOSENACCORDINGTOSOMEINITIALIZATIONRULEEG,RANDOMLYEACHANTBUILDSATOURIE,AFEASIBLESOLUTIONTOTHETSPBYREPEATEDLYAPPLYINGASTOCHASTICGREEDYRULETHESTATETRANSITIONRULEWHILECONSTRUCTINGITSTOUR,ANANTALSOMODIFIESTHEAMOUNTOFPHEROMONEONTHEVISITEDEDGESBYAPPLYINGTHELOCALUPDATINGRULEONCEALLANTSHAVETERMINATEDTHEIRTOUR,THEAMOUNTOFPHEROMONEONEDGESISMODIFIEDAGAINBYAPPLYINGTHEGLOBALUPDATINGRULEASWASTHECASEINANTSYSTEM,ANTSAREGUIDED,INBUILDINGTHEIRTOURS,BYBOTHHEURISTICINFORMATIONTHEYPREFERTOCHOOSESHORTEDGESANDBYPHEROMONEINFORMATIONANEDGEWITHAHIGHAMOUNTOFPHEROMONEISAVERYDESIRABLECHOICETHEPHEROMONEUPDATINGRULESAREDESIGNEDSOTHATTHEYTENDTOGIVEMOREPHEROMONETOEDGESWHICHSHOULDBEVISITEDBYANTSTHEACSALGORITHMISREPORTEDINFIG3INTHEFOLLOWINGWEDISCUSSTHESTATETRANSITIONRULE,THEGLOBALUPDATINGRULE,ANDTHELOCALUPDATINGRULEAACSSTATETRANSITIONRULEINTHEACSTHESTATETRANSITIONRULEISASFOLLOWSANANTPOSITIONEDONNODECHOOSESTHECITYTOMOVETOBYAPPLYINGTHERULEGIVENBY3IFEXPLOITATIONOTHERWISEBIASEDEXPLORATION3
        下載積分: 10 賞幣
        上傳時間:2024-03-13
        頁數(shù): 14
        4人已閱讀
        ( 4 星級)
      • 簡介:CHAPTER13THEDILEMMAOFPERFORMANCEAPPRAISALPETERPROWSEANDJULIEPROWSEABSTRACTTHISPAPERDEALSWITHTHEDILEMMAOFMANAGINGPERFORMANCEUSINGPERFORMANCEAPPRAISALTHEAUTHORSWILLEVALUATETHEHISTORICALDEVELOPMENTOFAPPRAISALSANDARGUETHATTHECRITICALAREAOFLINEMANAGEMENTDEVELOPMENTTHATWASBEENIDENTIFIEDASACRITICALSUCCESSFACTORINAPPRAISALSHASBEENIGNOREDINTHELATERLITERATUREEVALUATINGTHEEFFECTIVENESSOFPERFORMANCETHROUGHAPPRAISALSTHISPAPERWILLEVALUATETHEAIMSANDMETHODSOFAPPRAISAL,THEDIFFICULTIESENCOUNTEREDINTHEAPPRAISALPROCESSITALSOREEVALUATESTHELACKOFTHEORETICALDEVELOPMENTINAPPRAISALANDMOVESFROMTHEPSYCHOLOGICALAPPROACHESOFANALYSISTOAMORECRITICALREALISATIONOFAPPROACHESBEFOREREEVALUATINGTHECHALLENGETOREMOVESUBJECTIVITYANDBIASINJUDGEMENTOFAPPRAISAL131INTRODUCTIONTHISPAPERWILLDEFINEANDOUTLINEPERFORMANCEMANAGEMENTANDAPPRAISALITWILLSTARTBYEVALUATINGWHATFORMOFPERFORMANCEISEVALUATED,THENDEVELOPLINKSTOTHEDEVELOPMENTOFDIFFERENTPERFORMANCETRADITIONSPSYCHOLOGICALTRADITION,MANAGEMENTBYOBJECTIVES,MOTIVATIONANDDEVELOPMENTITWILLOUTLINETHEHISTORICALDEVELOPMENTOFPERFORMANCEMANAGEMENTTHENEVALUATEHIGHPERFORMANCESTRATEGIESUSINGPERFORMANCEAPPRAISALITWILLEVALUATETHECONTINUINGISSUEOFSUBJECTIVITYANDETHICALDILEMMASREGARDINGMEASUREMENTANDASSESSMENTOFPERFORMANCETHEPAPERWILLTHENEXAMINEHOWORGANISATIONSMEASUREPERFORMANCEBEFOREEVALUATIONOFRESEARCHONSOMERECENTTRENDSINPERFORMANCEAPPRAISALTHISCHAPTERWILLEVALUATETHEHISTORICALDEVELOPMENTOFPERFORMANCEAPPRAISALFROMMANAGEMENTBYOBJECTIVESMBOLITERATUREBEFOREEVALUATINGTHEDEBATESBETWEENLINKAGESBETWEENPERFORMANCEMANAGEMENTANDAPPRAISALITWILLOUTLINEPPROWSEBUNIVERSITYOFBRADFORD,BRADFORD,ENGLAND,UKEMAILPJPROWSEBRADFORDACUK195PTATICCHIED,BUSINESSPERFORMANCEMEASUREMENTANDMANAGEMENT,DOI101007/9783642048005_13,C?SPRINGERVERLAGBERLINHEIDELBERG201013THEDILEMMAOFPERFORMANCEAPPRAISAL197APPRAISALFEEDBACKBEYONDPERFORMANCEFORPROFESSIONALSANDMANAGERSTONEARLY95OFWORKPLACESINTHE2004WERSSURVEYSEETABLE131CLEARLYTHEUSEOFAPPRAISALSHASBEENTHEDEVELOPMENTANDEXTENSIONOFAPPRAISALSTOCOVERALARGEPROPORTIONOFTHEUKWORKFORCEANDTHECOVERAGEOFNONMANAGERIALOCCUPATIONSANDTHEEXTENDEDUSEINPRIVATEANDPUBLICSECTORS1322THEPURPOSEOFAPPRAISALSTHECRITICALISSUEISWHATISTHEPURPOSEOFAPPRAISALSANDHOWEFFECTIVEISITRESEARCHEDANDUSEDINPRACTICETHROUGHOUTORGANIZATIONSTHEPURPOSEOFAPPRAISALSNEEDSTOBECLEARLYIDENTIFIEDFIRSTLYTHEIRPURPOSERANDELL1994STATESTHEYAREASYSTEMATICEVALUATIONOFINDIVIDUALPERFORMANCELINKEDTOWORKPLACEBEHAVIOURAND/ORSPECIFICCRITERIAAPPRAISALSOFTENTAKETHEFORMOFANAPPRAISALINTERVIEW,USUALLYANNUAL,SUPPORTEDBYSTANDARDISEDFORMS/PAPERWORKTHEKEYOBJECTIVEOFAPPRAISALISTOPROVIDEFEEDBACKFORPERFORMANCEISPROVIDEDBYTHELINEMANAGERTHETHREEKEYQUESTIONSFORQUALITYOFFEEDBACK1WHATANDHOWAREOBSERVATIONSONPERFORMANCEMADE2WHYANDHOWARETHEYDISCUSSED3WHATDETERMINESTHELEVELOFPERFORMANCEINTHEJOBITHASBEENARGUEDBYONESCHOOLOFTHOUGHTTHATTHESEPROCESSCANNOTBEPERFORMEDEFFECTIVELYUNLESSTHELINEMANAGEROFPERSONPROVIDINGFEEDBACKHASTHEINTERPERSONALINTERVIEWINGSKILLSTOPROVIDETHATFEEDBACKTOPEOPLEBEINGAPPRAISEDTHISHASBEENDEFINEDASTHE“BRADFORDAPPROACH”WHICHPLACESAHIGHPRIORITYONAPPRAISALSKILLSDEVELOPMENTRANDELL,1994THISAPPROACHISOUTLINEDINFIG131WHICHIDENTIFIESTHELINKAGESBETWEENINVOLVING,DEVELOPING,REWARDINGANDVALUINGPEOPLEATWORK1323HISTORICALDEVELOPMENTOFAPPRAISALTHEHISTORICALDEVELOPMENTOFPERFORMANCEFEEDBACKHASDEVELOPEDFROMARANGEOFAPPROACHESFORMALOBSERVATIONOFINDIVIDUALWORKPERFORMANCEWASREPORTEDINROBERTOWENS’SSCOTTISHFACTORYINNEWLANARKINTHEEARLY1800SCOLE,1925OWENHUNGOVERMACHINESAPIECEOFCOLOUREDWOODOVERMACHINESTOINDICATETHESUPERINTENDENT’SASSESSMENTOFTHEPREVIOUSDAY’SCONDUCTWHITEFOREXCELLENT,YELLOW,BLUEANDTHENBLACKFORPOORPERFORMANCETHETWENTIETHCENTURYLEDTOFWTAYLORANDHISMEASUREDPERFORMANCEANDTHESCIENTIFICMANAGEMENTMOVEMENTTAYLOR,1964THE1930STRAITSAPPROACHESIDENTIFIEDPERSONALITYANDPERFORMANCEANDUSEDFEEDBACKUSINGGRAPHICRATINGSCALES,AMIXEDSTANDARDOFPERFORMANCESCALESNOTINGBEHAVIOURINLIKERTSCALERATINGSTHISWASUSEDTORECRUITANDIDENTIFY
        下載積分: 10 賞幣
        上傳時間:2024-03-13
        頁數(shù): 12
        7人已閱讀
        ( 4 星級)
      • 簡介:焦爐煤氣在活性碳作用下干燥重整合成甲醇焦爐煤氣在活性碳作用下干燥重整合成甲醇摘要摘要焦爐煤氣在以活性炭為催化劑進行干燥重整已經(jīng)被研究用來生產(chǎn)合適的甲醇合成氣,這項工作的主要目的是研究焦爐煤氣中氫數(shù)量對焦爐煤氣干燥重整的影響,以及其它條件的影響,利如溫度和體積空速的影響。結(jié)果發(fā)現(xiàn),反向水煤氣變換(RWGS)反應的發(fā)生是由于焦爐煤氣中氫的存在,而且它對反應的影響隨著溫度的降低過程而增加。這種情可能引起的焦爐煤氣中的氫組成的變化,并由此預計。這種反應可以在約1000度的高溫下生產(chǎn)適合用于合成甲醇的合成氣。結(jié)果還發(fā)現(xiàn),空速的增加對水煤氣變換反應有利。此外,活性炭被證明是最適合焦爐煤氣生產(chǎn)合成甲醇的合成氣的催化劑。關鍵詞關鍵詞焦爐煤氣焦爐煤氣干重整,合成氣,甲醇干重整,合成氣,甲醇1簡介合成氣是大多數(shù)氫產(chǎn)品和各種有機物的生產(chǎn)原料,它主要由氫氣和一氧化碳組成,它基本上產(chǎn)自天然氣和石油,但有限的化石燃料的供應和應對氣候變化以及溫室氣體(GHG)的排放,加強了對生產(chǎn)的替代工藝,如生物質(zhì)氣化1或沼氣重整研究3。焦爐氣體(焦爐煤氣),它可以被認為是焦化廠的副產(chǎn)品,主要由氫氣(5560%),甲烷(2327%),一氧化碳(58%)和N2(35%),以及其他碳氫化合物,其中硫化氫和氨的比例小。這種氣體大部分是用作煉焦爐和鋼鐵廠的燃料,但往往對過剩焦爐煤氣的使用不能使用這種方式,所以通常放散燃燒,這也引起了環(huán)境污染的問題和如何解決環(huán)境的問題49。對于多余的焦爐煤氣如何處理,我們可以通過氫分離手段加以利用或通過部分氧化8,10,11蒸汽重整7,12,14,15或干燥重整4,5,16來生產(chǎn)合成氣12,13,生。這樣生產(chǎn)的合成氣可以反過來用于不同其他有機合成產(chǎn)品,主要是甲醇。雖然大多數(shù)研究者都集中在焦爐煤氣水蒸汽轉(zhuǎn)化法的研究,在過去的幾年焦爐煤氣干燥重整也已經(jīng)被深入的研究4,5,16。由于它提供了比水蒸汽重整更理想的反應條件和環(huán)境,如二氧化碳消耗的能源或節(jié)能,有著許多優(yōu)勢。另一個重要的優(yōu)勢在于焦爐煤氣干燥重整的好處是獲得了氫氣和一氧化碳的比率約2的合成氣,這是一個理想中合成甲醇的合成氣的比率17,18圖中所示只有一個步是提供甲烷和二氧化碳反應時的化學計量條件。從圖1中可以看出,這個過程可以被視為一種方法,即二氧化碳的部分再偱環(huán)、部分參加反應“,在理論上甲醇燃燒時會產(chǎn)生一半的二氧化碳。這項技術的研究的前景是深遠的,由于汽車燃料對甲醇的需求,和氫燃料電池或生物柴油的原料量的迅速增加19。這項工作主要目的是對焦爐煤氣的干燥重整的研究,以生產(chǎn)合適的原料氣H2/CO作為合成甲醇的合成氣。焦爐煤氣干燥重整中的活性炭,已被證明是一個對甲烷干燥重整有效的催化劑。氫氣數(shù)量是影響焦爐煤氣干燥重整和其它反應條件,如溫度或空速度,是目前研究重心。甲烷和從甲烷干重整造成二氧化碳轉(zhuǎn)換的變化。正如圖3所示,甲烷轉(zhuǎn)化降至40%以下開始的反應,反應6小時后達到20%左右。仔細的觀察,在減少可能由于初始不穩(wěn)定的第一分鐘。此外,二氧化碳轉(zhuǎn)化率比在干燥的甲烷重整(圖2),這表明RWGS比對的平衡轉(zhuǎn)移效應的影響更大。在冷凝器收集的大量水,約占8VOL%反應的產(chǎn)品,這個也是由其他研究者報告的建議16。除了降低氫氣的產(chǎn)量和改變H2/CO比,水也會阻礙甲醇合成,因為它會使銅催化劑的失能的影響23。31.溫度的影響圖4顯示了在900℃時的三元混合氣體干燥重組反應??梢钥闯?,此時甲烷轉(zhuǎn)化率大于50%,在整個反應實驗中可以看出,這個轉(zhuǎn)化率是800℃時測試所達不到的,CO2的轉(zhuǎn)化率也高于它在800℃的。由于RWGS反應(反應2)小于甲烷干重整(反應1)吸熱,反應溫度的增加提高了干燥改革吸熱,便出現(xiàn)了較高的甲烷轉(zhuǎn)化率,因此,會產(chǎn)生更多的氫,而水則會減少。實際上,隨著CO2轉(zhuǎn)化率的增加,會使干燥重整反應增強,而不是RWGS反應,因為反應所需的水量,在近3次的實驗明中顯低于800℃時的。其他可能的解釋是甲烷水蒸在高溫度下進行重整(反應3)。但是,這個機制似乎不太可能,因為它會導致甲烷和二氧化碳的轉(zhuǎn)換而沒有發(fā)生類似的增量,在圖4中可以看到。然而,RWGS反應(反應2)和蒸汽重整反應(反應3)引起的干重整反應(反應1),這使得難以區(qū)分此種反應遵循什么樣的規(guī)律。圖5顯示了在1000℃時所進行的測試的轉(zhuǎn)換結(jié)果。反應溫度的增加同時也增加了轉(zhuǎn)換結(jié)果,多達80%的甲烷和95%的二氧化碳的實驗后6小時。此外,在1000℃時沒有水的生產(chǎn)。所以,在此溫度下工作,它有可能避免水煤氣變換的發(fā)生,最大限度地利用氫。32空速的影響的體積空速在900℃和1000℃研究空速對反應過程的影響。在800℃溫度,因為在空速增加而導致轉(zhuǎn)換物的進一步減少20和水的形成,這將使它很難研究的空速變化和對反應進程的影響。三元混合氣體在900℃時采用三種不同的空速(分別是075,1,15LGH小時下進行干燥重整反應,圖6所示反應的結(jié)果??梢钥闯?,甲烷和二氧1?1?化碳的轉(zhuǎn)換是受空速變化的影響。因此,轉(zhuǎn)換率的影響在于空速變化,轉(zhuǎn)換率隨著空速增加而降低。隨著水煤氣變換反應空速增加。反應器中二氧化碳濃度的也增加。由于存在較高氫氣的含量,二氧化碳可能是限制水煤氣變換反應的物種。因此,二氧化碳的轉(zhuǎn)換應避免高的轉(zhuǎn)換,以防止水煤氣變換的副反應。圖7顯示了通過在1000℃和075LGH和150LGH時兩次測試,出1?1?1?1?現(xiàn)了兩種不同的結(jié)果。正如上文所述,在反應條件為075LGH1000℃時不1?1?產(chǎn)生水。當空速增加到150LGH小時,則會產(chǎn)生一些水,由于干重整反應1?1?
        下載積分: 10 賞幣
        上傳時間:2024-03-12
        頁數(shù): 26
        16人已閱讀
        ( 4 星級)
      關于我們 - 網(wǎng)站聲明 - 網(wǎng)站地圖 - 資源地圖 - 友情鏈接 - 網(wǎng)站客服客服 - 聯(lián)系我們

      機械圖紙源碼,實習報告等文檔下載

      備案號:浙ICP備20018660號